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Abstract 
 
In this research project, structural aspects of monomeric NADP+-dependent isocitrate 
dehydrogenase from Corynebacterium glutamicum (CgIDH) are investigated together with site-
directed mutagenesis and fluorescence spectroscopy studies. CgIDH, one of the enzymes of the 
Krebs cycle, catalyzes the decarboxylation of isocitrate into α-ketoglutarate, which in some 
bacteria and plants regulates the flow of carbon into either the Krebs cycle or the glyoxylate 
 
 bypass depending on the available carbon source. The structure of CgIDH complexed with 
Mg2+ has been determined at 1.75 Å resolution using X-ray crystallography. In contrast to the 
closed conformation of published structures of monomeric NADP+-dependent IDH from 
Azotobactor vinelandii complexed with either isocitrate-Mn2+ or NADP+, the structure of 
CgIDH complexed with Mg2+ demonstrates the open conformation. The superimposed structure 
of CgIDH complexed with Mg2+ onto the structures of AvIDH complexes reveals that Domain 
II is rotated ~24° or ~35º, respectively, relative to Domain I when isocitrate-Mn2+ or NADP+ is 
bound, resulting in the closure of the active site between the two domains. Fluorescence 
spectroscopic studies support the proposal that the presence of isocitrate or NADP+ could 
mediate the conformational changes in CgIDH.  
In addition, three CgIDH mutants (S130D, K253Q, and Y416T) were created based on 
the structural analysis and previous mutagenesis studies of homodimeric NADP+-dependent 
IDH. Both the specific activities and the fluorescence spectra of these CgIDH mutants elucidate 
the roles of these active site residues in CgIDH catalysis. It has been suggested that the 
conformational changes observed in the presence of the substrate(s) may regulate enzymatic 
activity in CgIDH, in contrast to homodimeric NADP+-dependent IDH in Escherichia coli, 
where the phosphorylation cycle controls activity. It is also presumed that both Lys253 and 
Tyr416 may play critical roles in CgIDH activity, as do the equivalent residues in homodimeric 
IDH from porcine heart mitochondria. Similar structural features and conformational changes 
among monomeric CgIDH and homodimeric NADP+-dependent IDH enzymes suggest the 
phylogenetic relationships among various monomeric and homodimeric NADP+-dependent IDH 
from different sources. 
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 Chapter 1 Introduction 
1.1 Isocitrate dehydogenase (IDH) 
1.1.1 General properties 
     Isocitrate dehydrogenase (IDH) is one of the enzymes involved in the Krebs cycle. This 
enzyme catalyzes the oxidative decarboxylation of 2R, 3S-isocitrate with NAD(P)+ to yield α-
ketoglutarate, CO2 and NAD(P)H. This catalytic reaction requires a divalent metal cation such as 
Mg2+ or Mn2+.  
            Isocitrate + NAD(P)+ ↔ α-ketoglutarate + CO2 + NAD(P)H 
Because isocitrate is decarboxylated at the β-carbon position to yield carbon dioxide, and 
because NAD(P)+ is reduced to NAD(P)H, IDH belongs to the β-decarboxylating dehydrogenase 
family of enzymes. The amino acid sequences of IDH enzymes show less than 10% identity to 
other dehydrogenases except isopropylmalate dehydrogenase (IMDH), which is 23% identical to 
IDH. Because of this low identity to other dehydrogenases, it is believed that IDH has evolved 
differently from other dehydrogenases (Chen and Gadal, 1990). 
     The IDH enzymes are divided into two groups, NAD+- and NADP+-dependent, based on the 
coenzyme specificity.  NAD+-dependent IDH (EC 1.1.1.41) is hetero-oligomeric and is found 
only in eukaryotes, whereas NADP+-dependent IDH (EC 1.1.1.42) is ubiquitously present in 
both prokaryotes and eukaryotes. In general, NAD+-dependent IDH has a larger molecular mass 
than NADP+-dependent IDH, e.g. the NADP+-dependent pig heart enzyme is a tetramer of 340 
kDa molecular mass, and incidentally catalyzes an irreversible reaction (Chen and Gadal, 1990). 
The reaction catalyzed by NAD+-dependent IDH is allosterically regulated by AMP, citrate and 
its catalytic products (NADH and α-ketoglutarate). On the other hand, NADP+-dependent IDH 
catalyzes the same reaction in a reversible manner but no allosteric control has been identified 
(Chen and Gadal, 1990). NADP+-dependent IDH is further classified into homodimeric and 
monomeric structural forms. While most prokaryotes and eukaryotes have a homodimeric 
NADP+-dependent IDH with two identical subunits of 40-50 kDa, a few bacteria, including 
Vibrio species (Ochiai et al., 1979; Fukunaga et al., 1992; Steen et al., 1998), Mycobacterium 
bovis (Florio et al., 2002), Azotobactor vinelandii (Suzuki et al., 1995; Sahara et al., 2002) and 
Corynebacterium glutamicum (Eikmanns et al., 1995) contain a monomeric form of NADP+-
dependent IDH. 
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 1.1.2 Proposed reaction mechanism 
     According to the proposed catalytic mechanism (Figure 1.1) (Hurley et al., 1991; Stoddard 
and Koshland, 1993), the hydroxyl group of isocitrate is first deprotonated by an enzymatic 
general base. The resultant hydride is then removed and transferred to NAD(P)+ so that 
NAD(P)H is produced. Next, the intermediate, S-oxalosuccinate, is decarboxylated at the β-
carboxyl group. This intermediate associated with IDH releases carbon dioxide and then is 
protonated to generate α-ketoglutarate. 
 
1.1.3 Biological roles 
     The catalytic regulation of IDH plays an important role because isocitrate is a common 
intermediate for both the Krebs cycle and the glyoxylate bypass in plants and in some bacteria 
(Chen and Gadal, 1990). In the Krebs cycle, the oxidative decarboxylation of isocitrate is 
catalyzed by IDH to produce α-ketoglutarate. Isocitrate lyase, on the other hand, mediates the 
conversion of isocitrate into glyoxylate in the glyoxylate bypass (Figure 1.2). The glyoxylate 
bypass is the essential metabolic pathway to produce glucose from acetyl-CoA when acetate is 
the only carbon source available for growth. Some bacteria and plants possess this pathway in 
their mitochondria and in the glyoxysome, so that these organisms can adapt their metabolic 
processes, depending on the carbon sources available for their growth (Chen and Gadal, 1990). 
18 
         
Figure 1.1 The proposed reaction mechanism of NAD(P)+-dependent IDH (Hurley et al., 1991; 
Stoddard and Koshland, 1993). 
     NAD(P)+-dependent IDH converts 2R, 3S-isocitrate into α–ketoglutarate as well as NAD(P)+ 
into NAD(P)H and releases CO2. The half-arrows represent the direction of the catalytic reaction 
and the release of products (NADPH and CO2), and the curved arrows indicate the movements of 
electrons in the reaction. A general base (B) and a general acid (A) are from the enzyme. The 
coordination of the divalent metal cation (M2+) is drawn as a dashed line. 
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Figure 1.2 Central metabolism in some bacteria and in plants during growth on glucose and 
acetate. 
     Both the Krebs cycle and the glyoxylate bypass during growth on glucose and acetate, 
respectively, are illustrated. The dashed arrows represent metabolic pathways including several 
reactions, and the solid arrows show single reactions. The enzymes involved in the reaction are 
abbreviated and indicated in the circles. AK, acetate kinase; PTA, phosphotransacetylase, IDH, 
isocitrate dehydrogenase; ICL, isocitrate lyase; MS, malate synthase; PEPCK, 
phosphoenolpyruvate carboxykinase; PCx, pyruvate carboxylase; PEPCx, phosphoenolpyruvate 
carboxylase. Adapted from Gerstmeir et al., 2003. 
 
      Both NAD(P)H and α-ketoglutarate as the end products of the IDH catalysis are essential not 
only for energy production but also for the biosynthesis of other cellular components in higher 
organisms. Whereas NAD+-dependent forms of IDH participate in energy production via the 
electron transport system within the mitochondrial matrix, the function of the NADP+-dependent 
forms of IDH is not fully understood. It has been suggested that NADP+-dependent IDH could be 
involved in the biosynthesis of glutamate and other cellular compounds (Chen and Gadal, 1990). 
    Recently, an anti-oxidant effect of NADP+-dependent IDH has been suggested based on 
results showing that the number of surviving E. coli cells after ionizing radiation were reduced in 
the absence of IDH (Lee et al., 1999). The inactivation of NADP+-dependent IDH by nitric oxide 
has also been reported (Lee et al., 2002; Yang et al., 2002). Cardiac mitochondrial NADP+-
20 
 dependent IDH has also been shown to be modified by the lipid peroxidation product and 
inactivated in vivo and in vitro (Benderdour et al., 2003). These studies proposed that the 
NADP+-dependent IDH would play a role in a cellular defence mechanism against oxidative 
stress-induced damage because NADPH produced from IDH catalysis is a critical requirement 
for the reduction of free radicals. 
 
 
1.2 Homodimeric NADP+-dependent IDH from Escherichia coli (EcIDH) 
1.2.1 General properties 
NADP+-dependent IDH in Escherichia coli, (EcIDH) is a homodimer with molecular mass 
of ~45 kDa for each subunit and is encoded by the 1.9 Kb icd gene. It has been studied 
extensively in terms of its kinetic properties, mutagenesis, and structural analysis. Among the 
416 residues in each polypeptide chain of this enzyme, serine 113 was identified at the active site 
and as the crucial residue for the regulation of EcIDH activity (LaPorte and Koshland, 1983). 
The topology of the solved EcIDH structure revealed the absence of a typical nucleotide 
(NADP+)-binding site that is often observed in other NADP+-dependent dehydrogenases (Hurley 
et al., 1989). 
Regulation of EcIDH activity plays an essential role in E. coli to adapt the metabolic 
pathways, to the available carbon source (Holms and Nimmo, 1982). In the presence of glucose, 
the Krebs cycle, via EcIDH activity, prefers to produce catabolites and energy in the form of ATP 
and NADPH, required for the biosynthesis of other cellular components. In some bacteria and in 
plants, however, when growing on acetate as a sole carbon source, the glyoxylate bypass is 
utilized to prevent the loss of carbons from acetate so that acetate carbons are used for synthesis 
of further cellular constituents (Figure 1.2). Because these two different enzymes require the 
same substrate, the competition between EcIDH and isocitrate lyase toward isocitrate determines 
the direction of flow of isocitrate. From kinetic studies, the Michaelis-Menten constant (Km) 
values for EcIDH and isocitrate lyase were 8 µM and 600 µM, respectively (LaPorte et al., 
1985), indicating that EcIDH exhibits a much higher affinity toward isocitrate than does 
isocitrate lyase. In other words, EcIDH can bind to isocitrate effectively even at a low 
concentration of isocitrate, but isocitrate lyase requires a high concentration of isocitrate. Hence, 
EcIDH has to be inactivated and then lose its higher affinity toward isocitrate, so that isocitrate 
21 
 lyase is able to utilize isocitrate in the glyoxylate bypass. Therefore, EcIDH is the key enzyme 
which contributes major control over the flow of isocitrate into either the Krebs cycle or the 
glyoxylate bypass for bacterial growth, depending on the available carbon source (Holms and 
Nimmo, 1982; LaPorte et al., 1985). 
 
1.2.2 Phosphorylation cycle for regulation of catalytic activity 
     Phosphorylation as a means of regulation of EcIDH activity was first proposed as an example 
of protein phosphorylation, in which the specific endogenous substrate for the protein kinase had 
been identified (Garnak and Reeves, 1979). When E. coli was grown on acetate, EcIDH activity 
was significantly decreased, and EcIDH became phosphorylated (Garnak and Reeves, 1979; 
Reeves and Malloy, 1982). It has been suggested that inactivation of EcIDH via phosphorylation 
might switch on the glyoxylate bypass by isocitrate lyase so that bacteria can grow in the 
presence of acetate (Reeves and Malloy, 1982). This hypothesis was further supported by a study 
that showed that neither lower expression nor overproduction of IDH appeared to disturb E. coli 
growth on acetate (Garnak and Reeves, 1979). This indicated that a constant level of EcIDH 
activity could be maintained by converting EcIDH into the inactive form via a phosphorylation 
cycle. Such adaptation is probably dependent on growth conditions.  
     The phosphorylation of EcIDH occurs at a single serine residue, Ser113, according to various 
kinetic studies and structural analysis (Thorsness and Koshland, 1987; Hurley et al., 1989; Dean 
and Koshland, 1993). This serine residue was mutated to Ala, Cys, Thr, Tyr, Glu, and Asp, in 
order to determine the role of the functional group of its side chain and its impact on the 
phosphorylation cycle of EcIDH. The introduction of a negatively-charged side chain (Glu, Asp) 
completely inactivated EcIDH, whereas a neutral side chain lowered its catalytic activity 
(Thorsness and Koshland, 1987). Phosphorylated EcIDH was also detected only when the 
residue at position 113 was serine (Thorsness and Koshland, 1987). These results confirm that 
EcIDH would be inactivated when either a negatively-charged side chain or phosphorylation of 
the Ser residue was introduced at this position.  
     Two residues, Tyr160 and Lys230, at the active site in EcIDH have been also suggested as 
essential residues that interact with the β-carbon of isocitrate to release CO2 during 
decarboxylation (Lee et al., 1995). When Tyr160 was substituted by phenylalanine, the catalytic 
activity of this mutant was reduced by 250-fold (Lee et al., 1995). Furthermore, mutation of 
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 Lys230 to methionine lowered both the catalytic activity and the affinity toward isocitrate by 
100-fold and 500-fold, respectively (Lee et al., 1995). In addition, decarboxylation of 
oxalosuccinate was not detected for this mutant, suggesting a role for Lys230 in both substrate 
binding and decarboxylation (Lee et al., 1995). 
 
1.2.3 Structural studies 
1.2.3.1 Isocitrate-Mg2+complex 
     The first EcIDH structure (PDB; 5ICD) solved to 2.5 Å resolution revealed that the 
topology of this EcIDH dimer was different from the other known dehydrogenase structures 
(Hurley et al., 1989, 1990). The tertiary structure consisted of three domains for each subunit, a 
large domain, a small domain, and a clasp-like domain (Figure 1.3). The large domain spanned 
residues 1-124 and 318-416 and contained both the N and C termini, which formed eight α-
helices (a-d and j-m) and five β-strands (A-E), respectively. The small domain consisted of 
residues 125-157 and 203-317 with a typical α/β sandwich structure, formed from four α-helices 
(f-i) and six β-strands (F-L). The clasp-like structure was formed from one α-helix (e) and two β-
strands (M-N) corresponding to residues 158-202. This clasp region in the EcIDH dimer 
structure is unique because it is composed of two α-helices and four-stranded anti-parallel β-
strands, of which one α-helix and two β-strands are donated by each of two subunits, indicating 
that this unique clasp region would play a role for the dimer interlock. The proposed 
phosphoserine residue, Ser113, was also identified to lie on the protein surface at the edge of the 
pocket between two domains, suggesting that this residue would be accessible to IDH 
kinase/phosphatase (IDHK/P) in the EcIDH phosphorylation cycle (Hurley et al., 1989, 1990). 
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Figure 1.3 Overall structure of one subunit of EcIDH. 
     The cylinders labelled with lower case letters represent α–helices; the arrows form β-strands 
labelled with capital letters; and the string indicates the random coils of the structure. The 
phosphoserine residue, Ser113, is underlined in red. The blue stick shows the two-fold axis 
present in the dimer. Adapted from Hurley et al., 1989, 1990. 
 
 
     The structure of EcIDH complexed with isocitrate and Mg2+ (PDB; 5ICD) has also been 
determined to 2.5 Å resolution (Hurley et al., 1991). The divalent metal cation, Mg2+, was 
coordinated by Asp307, Asp283´ (the prime represents a residue from the second subunit of the 
dimer), and two water molecules in an octahedral arrangement. The Mg2+ cation was also 
coordinated to the α-carboxylate and the α-hydroxyl oxygen of isocitrate in order to stabilize the 
negative charge formed on the hydroxyl oxygen when isocitrate is converted to α–ketoglutarate 
during decarboxylation and dehydrogenation. Isocitrate is bound at the pocket between the large 
and small domains of each subunit, and hydrogen bonds are formed between isocitrate and 
Ser113, Arg119, Arg129, Arg153, Tyr160 and Lys230′ (Figure 1.4). While five water molecules 
interacted with isocitrate-Mg2+, Asn115 was also a possible candidate to interact with isocitrate. 
Compared to the IMDH structure (Wallon et al., 1997), Ser113 and Asn115 appeared to be 
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 unique residues that interact with the γ–carboxylate of isocitrate, indicating the substrate 
specificity of EcIDH. 
 
 
            
Figure 1.4 The active site in the structure of EcIDH complexed with isocitrate-Mg2+. 
    The side chains and isocitrate were observed at the cleft of the two subunits in the EcIDH 
structure. The solid lines represent the side chains of the residues and isocitrate at the active site. 
Possible hydrogen bonds or salt bridges are shown as dashed lines. The residues labelled with a 
prime symbol indicate a residue from the second subunit. Adapted from Hurley et al., 1991. 
 
1.2.3.2 NADP+ complex 
     The 2.5 Å resolution structure of EcIDH complexed with NADP+ (PDB: 9ICD) identified the 
NADP+ binding site that is located at the interdomain cleft (Hurley et al., 1991). The adenine 
moiety appeared to form hydrogen bonds with Asn352, Tyr391, and His339 whereas the 2’-
phosphate hydrogen bonded to Tyr345, Tyr391 and Arg395 as well as to Arg292´ from the 
second subunit (Figure 1.5). These residues at the NADP+ binding site are not conserved as well 
as those at the isocitrate binding site between EcIDH and IMDH. In terms of topological folds, 
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 the NADP+-binding site in the EcIDH structure seems to be distinct from the nucleotide-binding 
sites observed in the other dehydrogenase structures, supporting the hypothesis that the evolution 
of EcIDH could be different from the other decarboxylating dehydrogenases (Hurley et al., 
1991). 
 
         
Figure 1.5 Stereo diagram of the NADP+ binding site in the structure of EcIDH complexed with 
fragments of NADP+. 
     The solid bonds represent well-ordered fragments of NADP+ (2’-phosphate and adenine 
moieties), and the protein residues are drawn with open bonds. Residues from the second subunit 
are labelled with a prime symbol. Adapted from Hurley et al., 1991. 
 
1.2.3.3 Isocitrate-Ca2+ and NADP+ complex 
     When Mg2+ was substituted by Ca2+, EcIDH catalytic activity was reduced by a factor of 
2.5×10-3 without a change in the Km values for the substrates (Mesecar et al., 1997). The EcIDH 
structure in complex with isocitrate-Ca2+ and NADP+ has been determined to 1.9 Å resolution 
(PDB; 1AI2). The substitution of Mg2+ by Ca2+ caused a rearrangement of water molecules 
resulting in the formation of an 8-coordination geometry for Ca2+ and its relocation compared to 
the position of Mg2+. This allowed Ca2+ to interact with a water molecule that hydrogen bonded 
to the carbonyl oxygen atom of Thr338 (Figure 1.6). These changes resulting from the 
substitution of the divalent cation also adjusted the positions of isocitrate and NADP+ so that the 
distances from active site residues and the dihedral angles for NADP+ and isocitrate are altered, 
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 resulting in lower catalytic activity. From these differences observed between isocitrate-Mg2+ 
and -Ca2+ bound EcIDH structures, it can be concluded that small structural alterations of the 
enzyme and substrates may play an important role in catalytic activity. 
 
       
Figure 1.6 Coordination geometry of Mg2+ and Ca2+ ions bound in the structure of EcIDH 
complexed with isocitrate and NADP+. 
     (A) The Mg2+ ion (blue sphere) is coordinated with octahedral geometry. (B) The 8-
coordination of the Ca2+ ion (purple sphere) was observed in the EcIDH structure complex with 
isocitrate, Ca2+ and NADP+. The yellow lines show the possible coordinations of the metal 
cations. The white dashed lines represent hydrogen bonds. C4 is the carbon atom of NADP+; the 
light green coloured spheres are water molecules. Adapted from Mesecar et al., 1997. 
 
1.2.3.4 IDH kinase/phosphatase (IDHK/P) complex 
     The phosphorylation cycle of dimeric NADP+-dependent IDH in E. coli is catalysed by a 
bifunctional enzyme, isocitrate dehydrogenase kinase/phosphatase (abbreviated as IDHK/P). 
This enzyme is homodimeric with a molecular mass of ~68 kDa for each subunit and is encoded 
by a single gene, aceK (Cortay et al., 1988). Because mutation in the aceK gene increased the 
EcIDH activity by 3-fold, and because the loss of the IDHK/P activity decreased E. coli growth 
on acetate, IDHK/P was considered as a rate-limiting catalyst in the phosphorylation cycle of 
EcIDH (Stueland et al., 1988; LaPorte, 1993)  
     Although attempts to co-crystallize of IDH and IDHK/P were not successful, a new different 
EcIDH crystal structure was solved and refined to 2.42 Å resolution (PDB; 1SJS) (Finer-Moore 
et al., 1997). This structure showed that the large domain was rotated by ~16˚ with respect to the 
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 small domain and the clasp region of the subunit (Figure 1.7). Such an open conformation would 
allow IDHK/P to access Ser113 more easily for the phosphorylation of EcIDH. This newly 
observed conformation is quite similar to the one observed in the IMDH structure (Finer-Moore 
et al., 1997). Disruption of the NADP+-binding site due to the open conformation was also 
observed, suggesting that NADP+ prefers to bind to EcIDH in a closed conformation. It is 
hypothesized from these two different conformational forms of EcIDH that the equilibrium state 
between the energetically similar open and closed conformations may make this enzyme flexible 
for phosphorylation or dephosphorylation by IDHK/P in a reversible manner (Finer-Moore et al., 
1997). 
 
        
Figure 1.7 Two conformations for the structures of EcIDH in the absence and the presence of 
isocitrate-Mg2+. 
     The orthorhombic form on the left-side of the figure represents the open conformation of the 
EcIDH structure solved from the crystal that was unsuccessfully co-crystallized with IDHK/P. 
The tetragonal form is the closed form of the EcIDH structure in the presence of isocitrate-Mg2+. 
The left arrow denotes Ser113, and the right arrow, Asn232. The transition between the open and 
closed conformations causes a movement of Ser113 with respect to Asn232, as evident in this 
figure. Adapted from Finer-Moore et al., 1997. 
 
1.2.3.5 α-Ketoglutarate and Ca2+ complex 
     It has been proposed that EcIDH undergoes conformational changes upon binding of 
substrate(s) since soaking the substrate-free EcIDH crystals in a solution containing isocitrate, 
Mg2+, and NADP+ immediately destroyed the crystals (Stoddard and Koshland, 1993). The 
structure of EcIDH complexed with α-ketoglutarate and Ca2+ was determined to 2.7 Å resolution 
28 
 (PDB; 1IKA) (Stoddard and Koshland, 1993). Although α-ketoglutarate was bound at the active 
site in a similar manner to isocitrate, the structure of this complex was different from the other 
structures of EcIDH complexed with isocitrate-Ca2+ and NADP+ and those complexed with 
isocitrate-Mg2+. In the structure of EcIDH complexed with α-ketoglutarate and Ca2+, Ca2+ shifted 
by ~1 Å in distance from Ser113 compared to the Mg2+ in the isocitrate-Mg2+ complex, so that 
the Ca2+ was coordinated by α-ketoglutarate, Asp283, Asp307, Asp311, and two water molecules, 
resulting in a modified interaction between the metal ion and α-ketoglutarate at the active site. 
The major difference observed in this structure was the formation of a hydrogen bond between 
Tyr160 and Asp307. The Tyr160 that had bound to isocitrate in the Mg2+ complex shifted by 
more than 2.5 Å in the structure of EcIDH complexed with α-ketoglutarate and Ca2+ and formed 
a new hydrogen bond to Asp307, which induced the movements of the surrounding backbone 
regions, especially at the interdomain and the active sites. These rearrangements observed in the 
structure of EcIDH complexed with α-ketoglutarate and Ca2+, indicate that a local shift of EcIDH 
could be induced upon substrate binding, during the conversion of isocitrate to α-ketoglutarate. 
 
1.2.3.6 S113E mutant complex with isopropylmalate, Mg2+ and NADP+ 
     Inactivation of EcIDH by a Ser113 to Glu mutation is consistent with the evidence that 
phosphorylated EcIDH is inactive due to the introduction of the negative charge at this position 
(Thorsness and Koshland, 1987). The S113E mutant structure has been solved in complex with 
isopropylmalate, Mg2+ and NADP+ to 2.0 Å resolution (PDB; 1HJ6) (Doyle et al., 2001). This 
mutant structure is globally similar to other EcIDH structures, except that the interdomain hinge 
region and the loop of residues 255-263 are altered. Compared to the S113E mutant structure in 
the absence of substrate (PDB; 7ICD) (Hurley et al., 1990), a rigid body movement of one 
domain relative to the other was observed in this structure of the S113E mutant EcIDH 
complexed with ligands. Although such a conformational change is relatively small, the 
interdomain hinge angles are altered to cause the reorientation of the side chains at this region. 
Since the active site lies at this interdomain hinge, the N-terminal end of the active site d-helix 
(Figure 1.3) is tilted, and new hydrogen bonds among Asn115, Val116, and the mutated Glu113 
are formed. The positions of the backbone atoms at the loop and helix regions of the NADP+ 
binding site are shifted toward the catalytic site so that the binding of NADP+ would be possibly 
stabilized even in the presence of isopropylmalate (Figure 1.8). The upward shift of the loop 
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 connecting the NADP+ and isocitrate binding sites was also observed, suggesting that 
conformational flexibility at this region plays a role in EcIDH catalytic activity (Doyle et al., 
2001). 
 
                           
Figure 1.8 Comparisons of the active site in the structures of the complexes of EcIDH. 
     Four EcIDH structures; Ser113Glu mutant complexed with isopropylmalate, Mg2+ and 
NADP+ (abbreviated as IPM·IDHS113E) (purple), Apo-Ser113Glu (yellow), the Tyr160Phe mutant 
EcIDH complexed with isocitrate (blue) and the wild-type EcIDH complexed with 
isopropylmalate, Mg2+, and NADP+ (green) are overlaid at their catalytic sites. Ligands and Mg2+ 
are shown in ball-and-stick rendering, and residues 112 and 113 (and residue 121 for 
IPM·IDHS113E) are shown in stick rendering. Adapted from Doyle et al., 2001. 
 
 
1.3 Isopropylmalate dehydrogenase (IMDH) 
1.3.1 Crystal structures of IMDH 
     Another closely related dehydrogenase to EcIDH in terms of amino acid sequence and 
topology is IMDH which catalyses the dehydrogenation and decarboxylation of 2-
isopropylmalate to 2-oxoisocaproate and requires NAD+ and Mn2+. The amino acid sequence 
alignment between EcIDH and IMDH from E. coli (EcIMDH) shows 23% identity, and both 
enzymes are homodimeric. The substrate-free crystal structure of EcIMDH has been solved to 
2.06 Å resolution (PDB; 1CM7) (Wallon et al., 1997). It has a non-crystallographic 2-fold axis 
30 
 relating the two identical subunits, each with two domains, and two subunits are linked by a ten-
stranded anti-parallel β–sheet.  The large domain is formed from the N- and C-termini residues 
(1-105 and 256-363), and the small domain from residues 106 to 255. The active site is located 
between the two domains with residues donated by the two subunits. These topological features 
are similar to those found in EcIDH.  
      In addition, both open and closed conformations have been reported for the crystal structure 
of IMDH from Salmonella typhimurium (StIMDH) (PDB; 1CNZ) (Wallon et al., 1997).  The 
closed conformation of StIMDH complexed with Mn2+ and SO42- appeared more similar to the 
active, closed conformation of EcIDH rather than to the open conformation found in other 
IMDHs, indicating that the closed conformation in IMDH is indeed the active form. The divalent 
metal cation in the StIMDH complex is also coordinated in an octahedral geometry by Asp227', 
Asp255, Asp251, two water molecules and the sulfate ion (Figure 1.9). The sulphate ion further 
interacts with Tyr145 and Lys195, which are equivalent to Tyr195 and Lys350 at the active site 
in EcIDH. Based on these structural features, it is suggested that both homodimeric IDH and 
IMDH belong to the same dehydrogenase family.   
         
Figure 1.9 Stereo diagram of the structure of StIMDH complexed with Mn2+ and SO42-.  
    SO42- ion (SO4) is located near the non-leaving carboxylate of the substrate. Mn2+ ion (yellow 
sphere) is hexa-coordinated by three Asp residues (red stick bonds), SO42- (pink), and two water 
molecules (blue spheres), as the dashed lines indicate. The residues from the second subunit, are 
indicated by green stick bonds. This diagram was produced using Setor (Evans, 1993). 
 
 
1.4 Homodimeric NADP+-dependent IDH from porcine heart mitochondria (PmIDH) 
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 1.4.1 General properties 
     In porcine heart, homodimeric NADP+-dependent IDH enzymes are present in both the 
cytoplasm and mitochondria. These two forms share 70% sequence identity and are 
homodimeric with a molecular mass of 47 kDa per subunit. Cytosolic IDH possesses an anabolic 
function by generating NADPH for the reductive biosynthesis of the long-chained and 
unsaturated fatty acids (Belfiore and Iannello, 1995). The function of mitochondrial NADP+-
dependent IDH in mammals is not clearly understood; however, it seems to have a catabolic role 
in energy production and to be involved in the control of the oxidative damage (Jo et al., 2001).  
     Even though porcine heart mitochondrial NADP+-dependent IDH (PmIDH) is homodimeric 
like that of E. coli, amino acid sequences between mammalian and prokaryotic homodimeric 
NADP+-dependent IDH have only 16% sequence identity (Haselbeck, 1992). Also, the 
phosphorylation of PmIDH has not been reported to date. Therefore, the relationship between 
mammalian and prokaryotic homodimeric IDH enzymes has been investigated by structural and 
various mutagenesis studies. 
 
1.4.2 Structural studies 
     The structure of PmIDH complexed with isocitrate-Mn2+ has been solved to 1.85 Å resolution 
(PDB; 1LWD) (Ceccarelli et al., 2002). The structure shows a well-conserved active site in 
comparison with those of prokaryotic and eukaryotic dimeric NADP+-dependent IDHs. The 
metal ion is coordinated with two aspartate residues, two water molecules and two oxygens from 
isocitrate in an octohedral manner, similar to the EcIDH structure (Figure 1.10). One side chain 
at the active site also seemed to act as a base as occurs in EcIDH (Figure 1.1). Ser95 is identified 
as analogous to Ser113 in E. coli, and is located at the C-terminal end of the d-helix, the so-
called “phosphorylation loop” (Figure 1.3). 
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Figure 1.10 Coordination geometry of isocitrate-Mn2+ at the active site of PmIDH. 
     Mn2+ (pink sphere) is coordinated in the octahedral manner by Asp252′ (blue), Asp275 (red), 
two water molecules (light blue spheres) and two oxygens of isocitrate (green). The coordination 
is indicated by dashed lines, and the blue coloured residue is from the other subunit. This figure 
was produced from the use of Setor.  
 
     Major differences between PmIDH and EcIDH were found at the inter-subunit surface 
(Ceccarelli et al., 2002). While anti-parallel α-helices were stacked on top of the four-stranded 
anti-parallel β-sheets at the clasp region in EcIDH, four β-strands from each subunit, instead of 
the α-helices, produced the eight-stranded anti-parallel β-barrel at the clasp region in the 
structure of PmIDH complexed with isocitrate- Mn2+ (Figure 1.11). Moreover, the predicted 
NADP+-binding site based on the structural alignment suggested that the NADP+-binding site in 
PmIDH could be similar to that in EcIDH, except for two residues (Tyr345 and Tyr349 in 
EcIDH, and His315 and Lys375 in PmIDH, respectively) that would interact with the 2’-
hydroxyl-bound phosphate. These residues provide hydrogen bonds to the oxygen atoms of the 
2’-phosphate. When His315 was mutated to Gln, the Km value for NADP+ increased by 40-fold, 
supporting the proposal that this residue is involved in NADP+-binding (Huang and Colman, 
2002). Structural analysis of the NADP+-binding site with the structures of other complexes of 
PmIDH is still required to establish a more detailed mechanism of PmIDH. 
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Figure 1.11 Ribbon diagrams of the structure of PmIDH and comparing the clasp regions of 
PmIDH and EcIDH. 
     (A) The red and blue ribbons represent one subunit and the other, respectively in the structure 
of PmIDH complexed with isocitrate (white-yellow) and Mn2+ (orange). The clasp region is 
indicated by an arrow. (B) The clasp region of PmIDH is formed from eight β-strands, of which 
one set of four β-strands is donated from one subunit (red) and one set from the other (blue).  (C) 
The clasp region of EcIDH consists of anti-parallel α-helices laid on top of four β-strands. One 
set of one α-helix and two anti-parallel β-strands are donated from one subunit (red) and one set 
from the other (blue). Adapted from Ceccarelli et al., 2002. 
 
1.4.3 Mutagenesis studies 
     Based on the structure of PmIDH, Lys212 and Tyr140 were selected for mutagenesis since 
these residues are located close to bound isocitrate (Kim et al., 2003). Mutations of Lys212 to 
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 glutamate, tyrosine, or arginine exhibited only 0.01-9.0% of the specific activity of the wild-type 
enzyme. Similarly, each of the Tyr140 mutants was nearly inactivated when Tyr140 was mutated 
to phenylalanine, threonine, glutamate, or lysine. It has been proposed that Lys212 and Tyr140 
are critical in PmIDH catalytic activity (Kim et al., 2003).  
     Three other aspartate residues at the catalytic site, Asp252, Asp275 and Asp279, have been 
studied to elucidate their roles in PmIDH (Huang et al., 2004). In the PmIDH structure, Asp252 
and Asp275 coordinate Mn2+ along with two water molecules and two oxygen atoms of 
isocitrate, while Asp279 appears to link indirectly to Mn2+. When Asp252 and Asp275 have been 
separately mutated in PmIDH to His, their affinities for isocitrate and Mn2+ and their catalytic 
activities were significantly reduced, indicating that these Asp residues could be essential for the 
binding of isocitrate and Mn2+ (Huang et al., 2004). On the other hand, the D279H mutant 
showed lower affinity toward NADP+ rather than toward isocitrate and Mn2+, suggesting a role 
for this residue in coenzyme binding (Huang et al., 2004).  
 
 
1.5 Human cytosolic homodimeric NADP+-dependent IDH (HcIDH) 
1.5.1 General properties 
     Human cytosolic NADP+-dependent IDH (HcIDH) is homodimeric with a molecular mass of 
46.7 kDa for each subunit. Unlike mitochondrial NADP+-dependent IDHs, HcIDH possesses a 
peroxisomal target sequence at its C-terminus that allows it to localize in the peroxisomes and to 
provide the NADPH required for the β–oxidation of fatty acids (Belfiore and Iannello, 1995; 
Yoshihara et al., 2001). This enzyme has also been reported to play a cellular defence role 
against oxidative damage (Lee et al., 2002). As is the case with PmIDH, possible enzymes 
equivalent to E. coli IDHK/P have not been found in the human genome, and phosphorylation of 
HcIDH has not been reported to date. 
 
1.5.2 Structural studies 
1.5.2.1 NADP+, isocitrate, and Ca2+ complex  
     The homodimeric HcIDH structure consists of three domains with an overall structure similar 
to the other known homodimeric structures of EcIDH and PmIDH (Xu et al., 2004). The active 
site is also found at the hydrophilic region between the small and large domains of the same 
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 subunit (Figure 1.12). Like PmIDH, two layers of four stranded anti-parallel β-sheets form the 
clasp domains of two subunits. The major difference between HcIDH and EcIDH is observed at 
the small cleft located between the small and large domains. While this small cleft is mainly 
hydrophilic in EcIDH, it consists of both hydrophobic and hydrophilic residues in HcIDH. This 
feature suggests that this small cleft could be involved in the function and regulation of HcIDH. 
     The structure of HcIDH in complex with NADP+, isocitrate, and Ca2+ was solved and refined 
to 2.41 Å resolution (Xu et al., 2004). There are two homodimeric molecules with four sets of 
NADP+, isocitrate, and Ca2+ per asymmetric unit. This structure revealed that isocitrate interacts 
with Thr77, Ser94, Arg100, Arg109, Arg132, Tyr139, and Asp275 from one subunit and with 
Lys212, Thr241 and Asp252 from the adjacent subunit, in addition to interacting with three water 
molecules, NADP+, and Ca2+. These interacting residues are similar to those found in the PmIDH 
structure as well as in EcIDH, indicating that the catalytic residues are well conserved among 
prokaryotic and eukaryotic NADP+-dependent IDH enzymes. 
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 Figure 1.12 Ribbon diagrams of two HcIDH structures.  
     (A) The overall structure of HcIDH complexed with NADP+ exhibits an open conformation. 
(B) The overall structure of HcIDH complexed with isocitrate- Ca2+ and NADP+ shows a closed 
conformation. The large domain, the small domain, and the clasp region of one subunit of 
HcIDH are shown in green, blue, and red, respectively, while the second subunit is drawn in 
grey. Isocitrate (yellow gold), NADP+ (purple) and Ca2+ (a sky blue sphere) are bound at the 
active site. Adapted from Xu et al., 2004. 
 
1.5.2.2 NADP+ complex 
     The structure of HcIDH in complex with only NADP+ was also solved up to 2.7 Å resolution 
(Xu et al., 2004). In this structure, NADP+ was found to interact with residues at the active site 
of the large domain that is close to the isocitrate-binding site. The adenine moiety of NADP+ 
interacts with His309, Val312, Arg314, His315, Thr327 and Asn328 in both hydrophobic and 
hydrophilic manners (Figure 1.13). The 2’-phosphate group forms salt bridges with Arg314 and 
His315. Because Tyr345, Tyr391 and Arg395 interact with the 2’-phosphate of NADP+ in 
EcIDH, it is proposed that Arg314 and His315 determine the specificity of the NADP+ binding in 
HcIDH. Indeed, mutagenesis studies in PmIDH supported this hypothesis since the mutation at 
the equivalent His315 reduced the affinity of PmIDH toward NADP+ (Huang and Colman, 
2002). 
     Compared to the structure of HcIDH in complex with NADP+, isocitrate, and Ca2+, the 
structure of HcIDH in complex with NADP+ was observed to be in a more open conformation 
(Xu et al., 2004). Whereas the former structure was very similar to other known NADP+-
dependent IDH structures containing substrate(s), the NADP+ complex structure is a unique, 
open conformation in an inactive form (Figure 1.14). Detailed analysis of these structures shows 
that Asp279 interacts via hydrogen bonds with Ser94, Thr77 and Asn96 at the active site in the 
NADP+ complex structure. These interactions appear to prevent the occurrence of the closed 
conformation and thus binding of isocitrate, since Ser94 has been identified not only as an 
interacting residue with isocitrate, but also as the analogous residue to the key residue (Ser113) 
in EcIDH. The active site is also widely open in the structure of HcIDH complexed with NADP+, 
resulting in inactivation of this enzyme. 
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Figure 1.13 Stereo diagram of the NADP+ binding site in HcIDH. 
     NADP+ (green) is coordinated by the labelled residues (red stick bonds) (Xu et al., 2004). 
This figure was produced from Setor.  
 
     From these structural studies, it has been proposed that two inter-convertible conformational 
states of similar energy exist in mammalian NADP+-dependent IDH (Xu et al., 2004). The closed 
conformation seems to be induced by the hinge movements of the clasp and of the small domain 
with respect to the large domain when isocitrate binds to the catalytic site of the enzyme. It is 
suggested that inter-conversion between these conformational states in HcIDH could regulate its 
catalytic activity and would play a role in its function since similar conformational changes to 
control its enzymatic activity were also observed in EcIDH during the phosphorylation cycle. 
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Figure 1.14 Schematic illustration of the conformational changes in HcIDH. 
     The domains are drawn as coloured rectangular boxes to show the one subunit (yellow) and 
the other (blue). Small circles attached to the small domain represent Asp279 (D279) and Gln277 
residues. The ribbon shows Asp279 interacting with Ser94 (S94) in the open form. Adapted from 
Xu et al., 2004. 
 
 
1.6 Monomeric NADP+-dependent IDH 
1.6.1 General properties 
     Monomeric NADP+-dependent IDH is found in a few bacteria such as A. vinelandii (Suzuki et 
al., 1995 ; Sahara et al., 2002), C. glutamicum (Eikmanns et al., 1995), and Vibrio species 
(Ochiai et al., 1979 ; Fukunaga et al., 1992; Steen et al., 1998). No cross-reactivity against 
antibodies has been observed between homodimeric and monomeric NADP+-dependent IDH 
although both forms catalyze the identical reaction (Chen and Gadal, 1990). The molecular mass 
of monomeric NADP+-dependent IDH is ~80 kDa. There is less than 10% identity between 
amino acid sequences of homodimeric and monomeric NADP+-dependent IDH enzymes. These 
studies suggest that two different forms of NADP+-dependent IDH could have evolved 
separately. On the other hand, partial sequence alignment revealed that the catalytic residues 
between homodimeric and monomeric NADP+-dependent IDH are fairly conserved, indicating 
the possibility that one single unit of monomeric IDH could function similarly to two subunits of 
homodimeric IDH (Chen and Yang, 2000). 
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1.6.2 Structural studies of monomeric NADP+-dependent IDH structure from A. vinelandii 
(AvIDH) 
1.6.2.1 Isocitrate-Mn2+ complex 
     The relationship between homodimeric and monomeric NADP+-dependent IDH had not been 
discussed until the first monomeric IDH structure at 1.8 Å resolution was published (PDB; 
1ITW) (Yasutake et al., 2002). The crystal structure of monomeric IDH from A. vinelandii 
(AvIDH) revealed the presence of two distinct domains within the single polypeptide. A small 
domain (Domain I) is formed from both the C- and N-terminal regions and corresponds to the 
large domain (Domain A) in EcIDH. On the other hand, a large domain (Domain II) contains two 
symmetrically arranged Greek Key motifs and is homologous to the small domain (Domain B) 
and the clasp region (Domain C) of EcIDH (Figure 1.15). The presence of the pseudo 2-fold axis 
only in Domain II of AvIDH is also similar to the crystallographic 2-fold found in EcIDH, 
indicating the partial duplication of the common gene during the evolution to maintain the spatial 
form for the identical catalytic reaction (Yasutake et al., 2002).  
     The cleft formed between Domain I and II in the AvIDH structure creates the active site in a 
similar manner to the two subunits of homodimeric IDH (Figure 1.16). Although there are two 
active sites in EcIDH, the second catalytic site is absent in AvIDH because of the lack of the 
equivalent domain that would correspond to Domain A’ of the second subunit in EcIDH. From 
the comparison of the catalytic site of AvIDH onto one of the catalytic site of EcIDH, Ser132 in 
AvIDH was found to be analogous to Ser113 in EcIDH. In AvIDH, hydrogen bonds are formed 
between isocitrate and Ser132 as well as the other equivalent residues such as Asn135, Arg139, 
Arg145, Arg547, Tyr420 and Lys255 (Figure 1.16). The active site residues in AvIDH are 
completely conserved among monomeric IDH enzymes from other sources and are homologous 
with the active site of homodimeric NADP+-dependent IDH from numerous sources (Yasutake et 
al., 2002). These similarities implied that monomeric and homodimeric forms of NADP+-
dependent IDH could have possibly evolved from a common ancestral protein even though their 
primary structures are not significantly identical (Yasutake et al., 2002). 
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Figure 1.15 Schematic illustration of the tertiary structures of (A) AvIDH and (B) EcIDH. 
     (A) AvIDH consists of Domain I and II. (B) The first and second subunits in EcIDH are 
coloured in pink and orange, respectively. The domains in the second subunit in EcIDH are 
indicated with the prime symbol. Adapted from Yasutake et al., 2002. 
 
                          
Figure 1.16 Schematic illustration of the catalytic sites in AvIDH and EcIDH. 
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      The cross (×) represents the catalytic site(s) found in (A) AvIDH and in (B) EcIDH. 
Functionally corresponding residues are drawn as black spheres. Residues and domains from the 
second subunit in EcIDH are indicated by the prime symbol. Adapted from Yasutake et al., 2002.   
 
1.6.2.2 NADP+ complex  
     The structure of AvIDH complexed with NADP+ has been also solved to 3.2 Å resolution 
(PDB; 1J1W) (Yasutake et al., 2003). Even though the enzyme was originally crystallized from 
solution containing isocitrate-Ca2+ and NADP+, possibly due to the inhibition of the AvIDH by 
Ca2+, only NADP+ was present in the structure (Figure 1.17). The NADP+ binding site was 
observed at the active site cleft when NADP+ interacted directly with the residues from the small 
domain and both its adenine and nicotinamide ring were in the anti-conformation (Figure 1.18). 
Hydrogen bonds were formed between adenine and the residues His589, Arg600, Asp602, and 
Arg649. The diphosphate moiety has van de Waals contacts with Gly684, Ser585 and Ala586. 
The nicotinamide ribose moiety formed hydrogen bonds with Ser585, Ser87 and Asn85. These 
residues interacting with NADP+ are conserved among various monomeric IDH enzymes, but 
their equivalents are not found in EcIDH. Thus, monomeric AvIDH has a unique NADP+-binding 
site which is distinct from homodimeric IDH.    
                     
                                 
Figure 1.17 Ribbon diagram of AvIDH complexed with NADP+. 
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      NADP+ is represented as sticks-and-balls bound at the cleft in AvIDH. The α-helices of the 
AvIDH structure are drawn as ribbons; the β-sheets are drawn as arrowed-ribbons; and the 
random coils are illustrated as strings. Adapted from Yasutake et al., 2003. 
 
                   
Figure 1.18 Stereo diagram of the NADP+ binding site in AvIDH. 
     The blue loop represents the backbone of the protein. Three residues that interact with NADP+ 
(purple) are drawn with sticks-and-balls. Adapted from Yasutake et al., 2003.  
 
     The detailed structure of AvIDH complexed with NADP+ also revealed that the hydrogen-
bonding network between water molecules and Asp350 is well ordered and provides a proton 
acceptor for isocitrate at the active site, similar to that provided in the homodimeric PmIDH 
structure (Yasutake et al., 2003). In addition, a residue, analogous to His589, at the NADP+-
binding site of AvIDH is present in PmIDH. These structural observations suggest that 
monomeric IDH may be more closely related to mammalian homodimeric IDH rather than to 
prokaryotic homodimeric IDH. 
 
1.6.3 Monomeric NADP+-dependent IDH from C. glutamicum  
1.6.3.1 Industrial importance of C. glutamicum 
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      A gram-positive, non-pathogenic bacterium, C. glutamicum, is known as an amino acid 
producing organism since it is widely used in industry for the large scale production of amino 
acids, such as lysine and glutamate, for animal nutrition (Jetten et al., 1994). Annually, ~1 000 
000 tons of L-glutamate and ~450 000 tons of L-lysine are produced from these industrial C. 
glutamicum strains (Kalinouski et al., 2003).  
     This bacterium can grow on either glucose or acetate as the sole carbon source. One of the 
unique features of this bacterium as an industrial amino acid producer is the presence of a lysine 
specific export carrier (Bröer and Krämer, 1991). When the normal feedback inhibition of 
aspartate kinase by lysine during lysine synthesis is impaired, not only is this enzyme 
deregulated by the increased concentration of lysine, but also the activity of the lysine specific 
export carrier is increased (Bröer and Krämer, 1991).  As a consequence, massive production and 
secretion of lysine can be achieved from this bacterium. Various metabolic pathways have been 
studied to understand the mechanisms of amino acid production in C. glutamicum (Gerstmeir et 
al., 2003; Kiefer et al., 2004). The whole genome for the wild type strain of C. glutamicum has 
been reported (Ohnishi et al., 2002). 
 
1.6.3.2 The icd gene from C. glutamicum 
     Because C. glutamicum can grow on glucose or acetate, IDH is a key candidate enzyme to 
control the carbon flux at the branch point between the Krebs cycle and the glyoxylate bypass 
depending upon the carbon source available. The icd gene encoding monomeric NADP+-
dependent IDH from C. glutamicum has been identified and cloned into a shuttle vector of E. coli 
and C. glutamicum, named pEK (Eikmanns et al., 1995). There is only a single icd gene with 
3595 base-pairs present in C. glutamicum, the product of which is one single monomeric 
NADP+-dependent IDH (CgIDH). It was previously found that CgIDH activity is independent of 
the bacterial growth substrate and growth phase, but is likely involved in controlling the branch 
point between the Krebs cycle and the glyoxylate bypass. No enhanced secretion of glutamate 
was observed from the recombinant strain although CgIDH activity increased by about 10-fold. 
On the other hand, a mixture of oxaloacetate and glyoxylate significantly reduced CgIDH 
activity. It is suggested that CgIDH is not the rate-limiting enzyme for glutamate production but 
it is sensitive in some way to oxaloacetate and glyoxylate and could indirectly regulate the 
branch point between the Krebs cycle and the glyoxylate bypass (Eikmanns et al., 1995). 
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1.6.3.3 Kinetic properties of CgIDH 
     Although the overall sequence alignment has less than 10% identity between monomeric and 
homodimeric IDH, the partial sequence alignment suggested that the active sites would be 
conserved between monomeric and homodimeric IDH enzymes (Chen and Yang, 2000). 
According to kinetic studies on both EcIDH and CgIDH, CgIDH had higher catalytic activity 
and specificity for NADP+ than did EcIDH. In a separate experiment, Lys253 was mutated to 
methionine, based on the partial sequence alignment. The activity of this mutant enzyme was not 
detectable, indicating that Lys253 could be involved in the reaction catalyzed by monomeric IDH 
(Chen and Yang, 2000).  
 
 
1.7 Research Objectives 
     The objectives of my research were to express, purify, crystallize and solve the detailed X-ray 
structure of monomeric CgIDH as a substrate-free form and/or as a complex with its substrate(s). 
The X-ray crystallographic study of a protein is a powerful approach to obtain a three-
dimensional structural model that can establish the detailed catalytic and functional mechanism 
of the enzyme. 
     Preliminary purification and crystallization of CgIDH were successfully performed in our 
laboratory as well as initial X-ray diffraction studies (Bai et al., 1999; Audette et al., 1999). It 
was planned to use the structure as a basis for mutagenesis to further explore the mechanism and 
the functions of monomeric IDH. The detailed mechanism of CgIDH catalysis should also help 
elucidate how monomeric IDH controls the branch point between the Krebs cycle and the 
glyoxylate bypass in some bacteria and plants. 
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Chapter 2 Materials and Experimental Procedures 
2.1 Materials 
2.1.1 Reagents and supplies 
     Chemical reagents, enzymes, chromatographic, microbacterial and crystallographic supplies 
used for this project and names and addresses of suppliers are listed in Tables 2.1 and 2.2. 
 
Chemical reagents Supplier 
Acrylamide;Bisacrylamide solution (30%, 29:1) Bio-Rad Laboratories 
Adenosine triphosphate (ATP) Sigma-Aldrich 
Agarose, electrophoresis grade GIBCO BRL 
Ammonium persulfate Bio-Rad Laboratories 
Coomassie-Brilliant Blue R250 Kodak 
Dithiothreitol (DTT) Sigma-Aldrich 
Ethidium bromide Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) BDH/VWR International Ltd. 
Ethylene glycol Fluka/ Sigma-Aldrich 
Glutathione (reduced form) Sigma-Aldrich 
Glycerol BDH/VWR International Ltd. 
Isopropyl -D-thiogalactopyranoside (IPTG) Sigma-Aldrich 
Magnesium chloride (MgCl2) BDH/VWR International Ltd. 
2-methyl-2,4-pentanediol (MPD) Fluka/ Sigma-Aldrich 
2-morpholineethanesulfonic acid (MES) Sigma-Aldrich 
3-[N-morpholino] propane sulfonic acid (MOPS) Sigma-Aldrich 
Nicotinamide adenine dinucleotide phosphate, 
oxidized form (NADP+) 
Sigma-Aldrich 
Nitrogen (liquid) Praxair 
Phenol: Chloroform: Isoamylalcohol (25:24:1) Sigma-Aldrich 
Polyethylene glycol (PEG) 400 Fluka/ Sigma-Aldrich 
PEG 2000 monomethyl ether (MME) Fluka/ Sigma-Aldrich 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich 
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Triethanolamine (TEA) Sigma-Aldrich 
N,N,N',N'-Tetramethylethylene-diamine (TEMED) Amersham Biosciences 
Tris-[hydroxymethyl]aminomethane (Tris) BDH/VWR International Ltd. 
Trisodium-DL-isocitrate Sigma-Aldrich 
 
Enzymes Suppliers 
EcoRI Amersham Biosciences 
SalI Amersham Biosciences 
DpnI Stratagene 
TaqTM DNA polymerase Novagen 
T4 DNA ligase Novagen 
Pfu TurboTM DNA ligase Stratagene 
RNase Amersham Biosciences 
PreScissionTM protease Amersham Biosciences 
  
Chromatographic supplies Supplier 
Red Sepharose CL-6B Amersham Biosciences 
Glutathione Sepharose 4B Amersham Biosciences 
  
Microbiological supplies Supplier 
BactoTM-agar BD 
Tryptone peptone BD 
BactoTM-yeast extract BD 
  
Crystallographic supplies Suppliers 
Additive screening  Hampton 
Cryoloops Hampton 
Dow Corning High Vacuum Grease VWR International Ltd. 
Glass capillaries Hampton 
Silica Hydrogel TM  Hampton 
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24-Well VDX Plates Hampton 
Table 2.1 Chemical reagents, enzymes, chromatographic, microbacterial and 
crystallographic supplies used in this project. 
 
 
Suppliers Address 
Amersham Biosciences Amersham Biosciences, Baie d'Urfe, QC, Canada 
Bio-Rad Laboratories Bio-Rad Laboratories Ltd., Mississauga, ON, Canada 
BD  BD Biosciences Canada, Mississauga, ON, Canada 
BDH/VWR International Ltd. VWR International Ltd., Mississauga, ON, Canada 
Fluka/ Sigma-Aldrich Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
GIBCO BRL Web Scientific Ltd., Cheshire, England, UK. 
Hampton Hampton Research, Laguna Niguel, CA, USA. 
Kodak Eastman Kodak Company, Rochester, NY, USA. 
Novagen EMD Biosciences, Madison, WI, USA. 
Praxair Praxair, Saskatoon, SK, Canada 
Sigma-Aldrich Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
Stratagene Stratagene co., La Jolla, CA, USA. 
Table 2.2 Names and addresses of suppliers. 
 
 
2.1.2 Plasmid vectors 
     The protein expression vector, pGEX6p-1, was obtained from Amersham Biosciences. This 
vector is ~5.5 Kbp and consists of the LacI q gene, an ampicillin resistance gene, a taq promoter, 
a glutathione encoding gene, protease cleavage sites, and a multiple cloning site (MCS). 
 
2.1.3 Bacterial strain 
     E. coli DH5α and BL21 strains were obtained from GIBCO BRL, and competent cells were 
prepared by the methods described elsewhere in the literature. The E. coli icd- strain, EB106, was 
generously provided by the E. coli genetic stock center (Yale University). The XL1-Blue super-
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competent cells were included in the Quickchange® site-directed mutagenesis kit purchased 
from Stratagene. 
 
2.1.4 Bacterial growth media 
     Bacterial growth media were prepared as described by Miller (Miller, 1972). Luria Bertani 
(LB) medium contained 10 g tryptone peptone, 10 g NaCl and 5 g BactoTM-yeast extract per liter 
of distilled water. The medium was autoclaved at 125 ˚C and 18 psi. For preparation of LB agar 
plates, 15 g/L of BactoTM-agar was added to the liquid media prior to autoclaving. After 
autoclaving and cooling down media to room temperature, either ampicillin (100 µg mL-1) or 
kanamycin (30 µg mL-1) was added as described below.  
 
 
2.2 Purification of monomeric NADP+-dependent IDH from C. glutamicum 
2.2.1 Bacterial growth 
     The C. glutamicum cells that harbored the plasmid pEKicdES, containing the icd gene, were 
inoculated in 5mL of LB medium containing kanamycin (30 µg mL-1) and shaken at 30 °C 
overnight. The overnight culture was transferred to and incubated in 500 mL of medium and 
shaken at 30 °C overnight. The growth culture was harvested through centrifugation at 6 000 ×g 
at 4 °C for 20 min. The cell pellet was stored at -80 °C (Bai et al., 1999).  
 
2.2.2 Ammonium sulfate fractionation 
     The harvested cell pellet was re-suspended in Buffer A [25 mM 2-morpholineethanesulfonic 
acid (MES), pH 6.2, 2.5 mM MnSO4, and 2.5 mM DTT] and disrupted by ultrasonication at 50 
W (5 × 1 min bursts with 6 min intervals). The sonicated solution was centrifuged at 12 000 ×g 
at 4 °C for 20 min. The supernatant containing IDH was transferred to a fresh tube, and activity 
assay was performed on the crude extract. The cell lysis and activity assay steps were repeated 
ten times until no activity was detected in the crude extract. In this way, the maximum amount of 
IDH could be obtained from the crude extract. Ammonium sulfate (35% to 80% cut) at room 
temperature in solid form was added to the pooled crude extract while stirring on ice. The 
mixture was centrifuged at 12 000 ×g at 4 °C for 20 min after incubation on ice for 30 min. The 
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pellet was dissolved in a minimal volume of Buffer A and dialyzed against the same buffer 
overnight. 
 
2.2.3 Affinity chromatography purification 
     The dialyzed protein solution was loaded on a pre-equilibrated Red Sepharose CL-6B affinity 
column with Buffer A containing 20 mM NaCl, and then the column was washed with 10× the 
bed volume of Buffer A containing 0.15 M NaCl. Monomeric IDH protein was then eluted with 
Buffer A containing 4 mM trisodium-DL-isocitrate. The fractions containing high enzymatic 
activity were pooled together and their purity was checked by 8% SDS polyacrylamide gel 
electrophoresis (PAGE). The pooled fractions were dialyzed against Buffer A. Following 
concentration of IDH using an UltraFree Amicon centrifuge tube (Millipore), 2.5 mM DTT and 
10% glycerol were added and the concentrated protein solution was stored at -80 ºC. 
 
 
2.3 Crystallization of substrate-free and coenzyme-bound enzyme 
2.3.1 Crystallization trials 
A crystal is defined as a regular array of molecules exhibiting a consistent packing 
arrangement (Weber, 1997). Theoretically, a crystal grows only at the metastable phase, the 
region above the solubility curve and below the supersolubility curve in the phase diagram 
(Figure 2.1). Both the concentration and the solubility parameters of a protein, such as pH and 
precipitant concentration, affect the phases of the protein. Protein crystals will dissolve in the 
unsaturated phases, whereas nucleation and crystal growth compete in the labile phase of the 
supersaturation region (Weber, 1997). In the metastable phase, the activation energy of protein 
molecules favour the solid phase while the other precipitants remain in soluble forms, resulting 
in crystal growth. In short, the protein crystal grows through the time-course specific, interior 
aggregation of a protein in solution via a kinetic process when the protein concentration and the 
solubility parameters meet at the metastable phase (Figure 2.2). 
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Figure 2.1 Phase diagram of protein crystallization.  
     The solubility curve (solid) divides the phase space into unsaturated region (Unsaturation) 
and supersaturated region (Supersaturation). The supersaturated region is further divided into the 
labile and the metastable phases by the supersolubility curve (dashed). Adapted and modified 
from Weber, 1997.  
 
                  
Figure 2.2 The kinetic process of crystallization.  
     The process of crystal growth is schematically illustrated along an energy (∆G) vs. time 
course. The clear crystal is drawn as a cube whereas the non-crystal form of protein is illustrated 
as coils. Adapted from the website: http://www-
structmed.cimr.cam.ac.uk/Course/Crystals/Theory/phases.html. 
 
     There are five categorized methods for crystallization: bulk crystallization, vapour diffusion, 
dialysis, free interface diffusion, and batch. Among these methods, vapour diffusion was mainly 
used for the crystallization of CgIDH. This crystallization method is a time-dependent saturation 
of the protein solution via vapour equilibration between a protein-containing droplet and a 
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reservoir. As water vapour diffuses from the protein-containing droplet to the reservoir, 
supersaturation of the protein solution will be achieved, and so nucleation and protein crystal 
growth occur simultaneously (Weber, 1997; Ducruix and Giegé, 1999).  
    CgIDH was crystallized by the hanging-drop vapour diffusion method at room temperature 
under the conditions previously described by Audette et al. (1999). Reservoir solution was made 
of 25% polyethylene glycol (PEG) 2000 monomethyl ether (MME), 0.1 M Tris-HCl (pH 7.3), 
and 0.2 M MgCl2, while the drop consisted of 1 µL of CgIDH at a concentration of 5 mg mL-1 
and 1 µL reservoir solution. A CgIDH crystal with dimensions 0.3 × 0.1 × 0.05 mm was obtained 
within a week. 
Three additive and detergent screening kits from Hampton Research were used to 
optimize the crystallization conditions (Sousa, 1995). Various small molecules were added to the 
protein-containing droplet on a plastic cover slip, since such additives are likely able to 
manipulate specific interactions with the macromolecule and possibly to obtain better quality 
and/or size of crystals. 
     Direct interface crystallization in a glass capillary using agarose gel or Silica Hydrogel 
(Hampton Research) was also attempted to obtain a crystal supported in a gel matrix, which 
would be directly frozen in a stream of nitrogen, without exposing the crystal to air (Garcia-Ruiz 
et al., 2001; Lopez-Jaramillo et al., 2001). 
 
2.3.2 Cryo-crystallography 
     X-rays are parts of the electromagnetic spectrum with energy of 4×103-104 kJmol-1. A protein 
crystal is highly hydrated (30-75% solvent) and very fragile. Thus, a protein crystal can be easily 
damaged and even destroyed by prolonged exposure to X-rays during the diffraction data 
collection. Hence, a protein crystal is required to be frozen and it is diffracted at ∼100 K under a 
cold nitrogen stream resulting in less decay and destruction of the protein molecules. If an 
untreated hydrated protein crystal is frozen directly, on the other hand, ice formation increases 
the volume of solvent content damaging the orderly packing of molecules within the protein 
crystal. Therefore, addition of a cryoprotectant is used to protect a protein crystal during flash 
cooling and from X-ray damage during diffraction (Ducruix and Giegé, 1999; Robert et al., 
1999). A proper cryoprotectant is critical to minimize any damage to the crystal from liquid 
nitrogen freezing and to achieve high resolution with low crystal mosaicity. 
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     One single cryoprotectant, such as ethylene glycol, glycerol, or mineral oil, is generally used 
to permeate a protein crystal (Hope, 1988; Garman and Schneider, 1997). Another method is to 
replace a high molecular weight polyethylene glycol (PEG) precipitant with a low molecular 
weight PEG400 which serves as a precipitant and a cryoprotectant, and it can be easily combined 
with another cryoprotectant due to its high viscosity. A two-step cryocrystallographic procedure 
has also been suggested, in which a crystal is permeated with a diffusible cryoprotectant and then 
transferred to an immiscible oil (Kwong and Liu, 1999; Riboldi-Tunnicliffe and Hilgenfeld, 
1999). Since the excess cryoprotectant around a crystal could be removed by passing the crystal 
through the immiscible oil, better resolution and lower crystal mosaicity of the crystal diffraction 
could be achieved. Additionally, mixtures, for example of glycerol and 2-methyl-2, 4-pentandiol 
(MPD), have been reported to work synergistically and give a better diffraction than one 
individual cryoprotectant alone (Fremont et al., 1996). 
For CgIDH crystals, various cryoprotectants, such as 5-25% glycerol, MPD, ethylene 
glycol and PEG400, mixed with reservoir solution were prepared and examined by the flash 
cooling method in order to optimize the cryocrystallographic conditions for successful 
diffraction data collection. Because CgIDH crystals tend to crack when exposed to the air, the 
crystals were soaked in a series of mixtures of reservoir and glycerol solutions from 10 to 25% 
(v/v) in 5% (v/v) increments, followed by transfer to light paraffin oil. Two cryoprotectant 
mixtures, glycerol and MPD, and glycerol and ethylene glycol, at different ratios of each of 
cryoprotectants were also tested. 
 
 
2.4 Data collection and processing 
When x-rays are diffracted by a protein crystal, the intensity and the position of the 
diffracted beam are measured. When an incoming X-ray at a certain wavelength (λ) hits a 
crystal, X-rays are re-emitted from the planes of the crystal as reflections and recorded as 
diffraction spots by a detector. The diffracted x-rays scatter in all directions as a form of 
electromagnetic energy released from the electrons of each molecule in the crystal. The resultant 
diffraction data consist of differences of individual amplitudes of the scattered waves diffracted 
by the crystal. 
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According to Bragg’s Law (Bragg, 1913), for constructive interference to occur, the 
integral multiple of the wavelength of the X-ray (λ) is equal to twice the distance (d) between 
two lattice planes, multiplied by the sine of the diffraction angle (θ) (Formula 2.1).  
 nλ= 2d hklsinθhkl       Formula 2.1 
Reflection indices, hkl, determine the reflecting planes, and the diffraction angle (θhkl) is 
the angle between the reflecting plane and the incident X-ray beam (Figure 2.3). Bragg’s law 
tells us that d-spacing of the crystal is reduced as the diffraction angle is increased at constant 
wavelength. In other words, the diffraction pattern is sensitive to the diffraction angle and 
spacing of the planes of a crystal. 
 
     
Figure 2.3 Schematic illustration of Bragg’s Law. 
     Both the incoming x-rays and the reflection from the adjacent planes are drawn as red arrows. 
Two lattice planes are drawn as thick black lines, which re-emit electrons when the x-ray strikes. 
The reflection angle and the perpendicular distance between two reflection planes are illustrated 
as θhkl and dhkl, respectively. Modified from Otwinowski and Minor, 1997. 
 
     The periodic arrangement of the collected diffraction pattern is mathematically related in a 
reciprocal manner to the actual crystal lattice (Otwinowski and Minor, 1997). The process to 
establish the periodicity of a diffraction pattern is done by a peak search. Then, the diffraction 
pattern is mapped from the peak search onto its reciprocal space so that the diffraction angles can 
be estimated. Based on the diffraction patterns determined from the peak search, the periodicity 
of the reciprocal lattice in the direction of the vector is searched automatically through a 
computational program in a process called autoindexing. This process finds the integer values of 
one index (h, k, or l) that are equivalent to the real-space vectors of the crystal because the 
reciprocal lattice space is represented as a vector that is normal (perpendicular) to the Bragg 
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planes with the inverse amplitude of the actual d-spacing within the crystal. As Bragg’s Law 
indicates, the inverse proportional relation between the diffraction angles and the d-spacing of 
the crystal at a constant wavelength means that the reciprocal space depends on the unit cell 
dimensions of the crystal. The three independent vectors, which would index almost all of the 
observed peaks, obtained from autoindexing are used to find the best unit cell dimensions of the 
crystal (Otwinowski and Minor, 1997). 
     The unit cell is defined as the smallest unit that makes up one crystal by simple translation in 
three dimensions. Each unit cell is formed from a, b, and c dimensions along x, y, and z axes 
respectively at α, β, and γ angles in three-dimensional space (McRee, 1993). In other words, a 
crystal is made up of the repetitions of the unit cell. These arrangements of the lattice points in 
space are classified into 14 space lattices called Bravais Lattices (Table 2.3). 
     The predicted unit cell dimensions from autoindexing are refined as the crystal and detector 
orientation parameters are fixed for each processed diffraction image since these parameters are 
slightly changed from one image to another during a rotation-based diffraction data collection. 
This process is done by integration, and further refinement, using the fixed unit cell dimensions, 
is performed by scaling (Otwinowski and Minor, 1997).  
     Diffraction data sets for three CgIDH crystals were collected on Beamline 14ID-B at the 
Advanced Photon Sources (APS), Argonne National Laboratory, in March 2003. Each data set 
was collected from a single CgIDH crystal on a MAR CCD detector at 100 K. Diffraction 
images from the flash-cooled crystal were taken at 1° increments per frame (10 s exposure per 
frame) for a 180° total rotation of the phi axis. 
 
Crystal 
System 
Bravais 
Type(s) 
External Minimum Symmetry Unit Cell 
Properties  
Triclinc P None a, b, c, α, β, γ  
Monoclinic P, C One 2-fold axis, parallel b (b 
unique)  
a, b, c, 90, β , 90 
Orthorhombic P, I, F Three perpendicular 2-folds a, b, c, 90, 90, 90 
Tetragonal P, I One 4-fold axis, parallel c a, a, c, 90, 90, 90 
Trigonal P, R One 3-fold axis a, a, c, 90, 90, 120 
Hexagonal P One 6-fold axis a, a, c, 90, 90, 120 
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Cubic P, F, I Four 3-folds along space diagonal a, a, ,a, 90, 90, 90 
Table 2.3 The classification of the Bravais Lattices. 
     The five Bravais types are primitive (P), centered (C), face-centered (F), body-centered (I), 
and primitive rhombohedral (R). The unit cell properties include the unit cell axes (a, b, c) and 
the angles (α, β, γ). The fixed angles in the crystal system (90, 120) are written in degrees. 
Adapted from International Tables for X-ray Crystallography, Volume I Symmetry Groups 
(Edited by Norman, H.F.M., and Lonsdale, K., 1967).  
 
A single crystal of CgIDH complexed with Mg2+ diffracted to 1.75 Å and belonged to 
space group C2, with unit cell dimensions of a =129.0 Å, b= 52.7 Å, c= 124.0 Å, and β = 108.9º. 
There was one molecule of monomeric IDH per asymmetric unit (ASU) with a solvent content of 
50.3 % and a Matthews coefficient (VM) of 2.43 Å3 Da-1 (Matthews, 1968). The diffraction data 
were indexed and integrated with the program HKL2000 (Otwinowski and Minor, 1997) and 
scaled with the program SCALA (Otwinowski and Minor, 1997). In addition, crystals of CgIDH 
in complex with either NAD+ or NADP+ diffracted to 2.10 Å and 2.04 Å, respectively, and their 
data sets were collected and processed as above. Both crystals belonged to the same space group, 
C2, as is the CgIDH crystal in complex with Mg2+ but with different unit cell dimensions. Unit 
cell dimensions were a =128.9 Å, b= 52.7 Å, c= 235.3 Å, and β = 103.5º for the NAD+-complex 
and a =128.4 Å, b= 52.5 Å, c= 234.4 Å, and β = 102.8º for the NADP+-complex. In 2004, 
diffraction data were collected at the APS to 2.5 Å resolution from a CgIDH crystal co-
crystallized with isocitrate and NAD+. This crystal again belonged to space group C2 with unit 
cell dimensions a =129.1 Å, b= 52.5 Å, c= 241.5 Å, and β = 108.5º. The diffraction data 
collection statistics for these four CgIDH crystals are summarized in Table 2.4. 
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CgIDH crystal 
complex 
Mg2+ NADP+ NAD+ Isocitrate- 
NAD+ 
Wavelength 
(Å) 
0.99 0.90 0.90 0.90 
Resolution 
limit (Å) 
50-1.75 
(1.81-1.75) 
50-2.04 
(2.11-2.04) 
50-2.10 
(2.18-2.10) 
50-2.50 
(2.59-2.50) 
Space group C2 C2 C2 C2 
Unit cell 
dimensions 
a = 129.0 Å, 
b= 52.7 Å, 
c= 124.0 Å,  
and 
β = 108.9° 
a = 128.4 Å, 
b= 52.5 Å, 
c= 234.4 Å, 
and 
β = 102.8° 
a = 128.9 Å, 
b= 52.7 Å, 
c= 235.3 Å, 
and 
β = 103.5° 
a = 129.1 Å, 
b= 52.5 Å, 
c= 241.5 Å, 
and 
β = 108.5° 
# of observed 
reflections 
151387 168976 141208 80182 
# of unique 
reflections 
79292 98067 90030 51709 
Completeness 
(%) 
99.2 
(95.6) 
93.2 
(98.6 ) 
85.3  
(76.1) 
86.3  
(84.3) 
I/σ 8.4 (1.66) 9.2 (4.40) 7.7 (2.15) 11.6 (4.40) 
Rsymm 0.072 (0.343) 0.087 (0.352) 0.087 (0.458) 0.153 (0.407) 
Table 2.4 Summary of diffraction data for CgIDH crystals complexed with various substrate(s). 
Statistical parameters after scaling are listed. Values in brackets are those for the highest 
resolution shell. Rsymm was calculated by Rsymm=Σ |I-<I>|/ΣI, where I = individual measured 
intensity and <I> = average of symmetry-related intensities.  
 
 
2.5 Solution and refinement of the CgIDH structure 
2.5.1 Molecular replacement 
     From diffraction data, only indices (h k l) and intensities of the reflection are measured. 
Phases are, however, required to solve the structure. Intensity (I) is proportional to the square of 
the amplitude of the structure factor (|Fhkl|) and is a real number. The structure factor (Fhkl), on 
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the other hand, is the summation of the scattering factors of atoms and is a complex number 
derived from: 
 Formula 2.2 
where the scattering factor (f(j)) of atom (j) is dependent on the kind of atom and the diffraction 
angle of the corresponding reflection. From the structure factors, the electron density is 
generated using a Fourier transform. The Fourier transform refers to the mathematical operation 
to transform the electron density into structure factors. In other words, the diffraction pattern is 
the Fourier transform of the electron density, and the structure factor amplitudes, but not phases, 
are obtained from the collected diffraction data. This lack of phase information is called 
the”phase problem” in X-ray crystallography. To solve the phase problem, the initial phases to 
start the model are required (McRee, 1993). 
     Molecular replacement (MR) is one of the phase techniques to determine the initial phases of 
a crystal structure from a known structure that has at least 30-40% amino acid sequence identity 
to the unknown structure (Brünger, 1997). The known structure (search model) is first rotated 
and then translated within the unit cell of the target crystal until the best fit was found between 
the observed and calculated diffraction data. Instead of comparing the structure factors, the 
summation of the square of the structure amplitudes with all phase angles equal to zero (known 
as Patterson functions) are used in MR. A Patterson peak is a measure of the vector between two 
atoms within the unit cell, and there are two types of Patterson vectors involving atoms of a 
molecule; self-Patterson and cross-Patterson vectors. The self-Patterson vectors are short intra-
molecular vectors to tell us the orientation of a molecule at the three rotation angles (α, β, γ) in 
the unit cell and are used during the rotation search. A higher peak solution in the rotation 
function usually corresponds to a better solution for the rotation search. If the possible solution 
peak is much higher than the other peaks, it indicates a correct solution. The cross-Patterson 
vectors, on the other hand, are inter-molecular vectors that provide information about the exact 
position of the atoms in the symmetry-related molecules within the unit cell in the translation 
search. The translation search is done along three translation axes (x, y, z). Three criteria, 
packing of the atoms, the R value and the correlation coefficient, are examined to determine the 
correct solution. The best solution should have a lower R value and a high correlation coefficient 
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with the least overlapping of the atoms in the unit cell. As a consequence, six parameters (three 
rotation angles and three translation axes) to place the search model into the unit cell of the 
crystal are determined and are further refined to start the model rebuilding and refinement since 
the amino acid residues may still form unique, variable conformations which differ from the 
search model (Brünger, 1997).  
     The first structure of CgIDH complexed with Mg2+ was solved by MR using the program 
CNS (Brünger et al., 1998) with the isocitrate-Mn2+ bound AvIDH structure (PDB; 1ITW) used 
as its search model. Due to the presence of two domains in the search model, the rotational 
orientation and the translational position for each domain were determined individually at first. 
The well-fitted domain with the higher correlation coefficient was fixed and the position of the 
other domain was searched. As a consequence, with the finding of the second domain, the 
correlation coefficient improved dramatically from 0.286 to 0.502. After relocating each domain 
using equivalent positions, the solved structure was examined with TURBO-FRODO (Roussell 
et al., 1990) and the domains were confirmed to be properly located in the unit cell without any 
overlapping of each other. For the rigid-body refinement, one domain was fixed as a reference to 
optimize the relative positions of the two domains in the asymmetric unit of the unit cell, and an 
Rcryst value of 0.433 was obtained after rigid-body refinement (McRee, 1993). 
 
2.5.2 Initial refinement 
     Refinement is the adjusting process of the atomic positions and B factors of the structure so 
that the calculated structure factors (Fcal) will resemble the observed structure factors (Fobs). Not 
only the protein molecules but also any ligands and solvent (water) molecules in the structure are 
adjusted during the refinement. The refinement is monitored by the crystallographic R value 
(Rcryst) and by the cross-validation R value (Rfree) (Brünger, 1992) (Formula 2.3 and 2.4). 
Approximately 5-10% of the observed reflections (‘T’ set of reflections) are randomly chosen 
and separated from the rest of the reflections to be used in the calculation of Rfree. While the Rcryst 
is dependent on the completeness, the resolution limit, and the accuracy of the diffraction data 
and the refinement process, Rfree can help validate the model entirely based on the diffraction 
data. 
         Rcryst = (Σ |Fobs- Fcal|) / Σ |Fobs|                       Formula 2.3 
         Rfree = (ΣT |Fobs- Fcal|) / ΣT |Fobs|                      Formula 2.4 
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     Using the initial phases from the MR solution, the electron density map is calculated by the 
Fourier transform (Formula 2.5). 
Formula 2.5 
Where V is the volume of the unit cell, |F(h,k,l)| is the structure factor amplitude of the reflection 
(hkl), x, y, and z are the coordinates of a point in the unit cell, and α(h,k,l) is the phase angle of any 
particular reflection (hkl). The starting model of the unknown structure will be modified 
according to the electron density map. The new electron density map is subsequently generated 
from the Fourier transformation after every cycle of refinement, resulting in a higher correlation 
between the calculated structure factors and the observed structure factors. 
     The initial refinement was performed using CNS (Brünger et al., 1998). Approximately 10 % 
of the reflections were randomly selected to calculate the Rfree value. Simulated annealing is a 
refinement process using molecular dynamics (Brünger, 1990). Because the potential energy of a 
molecule is proportional to a given temperature, the energy barrier of the atom is overcome 
computationally by increasing the temperature and assigning the potential energy at the high 
temperature. The assigned potential energy is then minimized as the temperature cools down step 
by step (slow-cooling); therefore, the atoms are relocated by their thermal motion and their 
dynamic behavior. The initial simulated annealing at 2.0 Å resolution improved Rcryst and Rfree 
significantly to become 0.339 and 0.377, respectively. Then, a B-factor refinement was 
performed resulting in 0.319 and 0.351 for Rcryst and Rfree, respectively. After energy 
minimization, the values to start the first modeling were Rcryst= 0.315 and Rfree= 0.348. The 
electron density maps were generated using CNS after a cycle of initial refinement (Read, 1986). 
In order to reduce model bias that is often present when MR is used to solve a structure, an omit 
map was generated by a simulated annealing SIGMAA weighted omit map method using 7.5% 
of the total number of reflections randomly selected for every cycle (Bhat, 1988; Hodel et al., 
1992). 
 
2.5.3 Manual modeling of the structure 
     Using TURBO-FRODO software (Roussell et al., 1990), the structure was manually adjusted 
by fitting each atom into the electron density map as well as examining other parameters of the 
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protein structure. For instance, the average bond distance between the Cα and the C of the main 
chain is ~1.53 Å, and the average bond distance between the C and the N of the main chain is 
~1.33 Å. A Ramachandran plot also provides information about the dihedral angles (phi and psi 
angles) of the main chain to help monitor the accuracy of the protein structure (Ramakrishnan 
and Ramachandran, 1965). After replacing the amino acid residues from the AvIDH search 
model with the ones present in CgIDH, Rcryst and Rfree were improved to 0.274 and 0.306, 
respectively. Water molecules were automatically picked using a CNS sub program (Brünger 
et al., 1998). Approximately 200 water molecules were picked and confirmed with TURBO-
FRODO to fit into the newly generated 2Fo-Fc map. After further refinement, the water 
molecules with B-factors above 40 Å2 were deleted. From the subsequent difference map (Fo-
Fc), some additional water molecules were manually added. Manual building of the structure 
followed by the simulated annealing, B-factor refinement, and generation of the electron density 
map were repeated. The electron density for Mg2+ was observed in both 2Fo-Fc and Fo-Fc 
maps. The coordination of this cation was obtained from the Hetero-compound Information 
Center in Uppsala (HIC-UP), Sweden (Kleywegt and Jones, 1998) and was included in further 
refinement. The final Rcryst and Rfree were 0.22 and 0.23, respectively, at 1.75 Å resolution, after 
checking the structure using the PROCHECK (Laskowski et al., 1996) from the CCP4 package 
(CCP4, 1994) and doing further adjustments. 
 
2.5.4 Calculation of the rotation angle 
In order to calculate a rotation angle between one domain of the structure and the 
equivalent domain of the other structure, two structures were first superimposed at one domain, 
using LSQKAB from the CCP4 package (Kabsch, 1976; CCP4, 1994). Then, another domain of 
the rotated structure was superimposed onto the subsequent domain of the other structure while 
the structural polar chi angle was set at the value obtained from the previous rotation. The 
structural polar chi angle from the second rotation corresponds to the rotation angle of the 
equivalent domain between two structures (CCP4, 1994) 
 
 
2.6 Site-directed mutagenesis of CgIDH 
2.6.1 Cloning the icd gene from C. glutamicum into an E. coli expression vector 
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2.6.1.1 Isolation of the plasmid DNA through ‘mini-prep’ 
     The plasmid DNA was purified by either the manual ‘mini-prep’ method (Birnboim and 
Doyle, 1979) or using the Wizard® Plus SV Minipreps DNA purification kit (Promega). The 
isolated colony was inoculated into 5 mL LB medium containing 100 µg mL-1 ampicillin and 
shaken at 37 °C overnight. The cells were harvested by centrifugation at 5 000 ×g for 20 min. In 
the manual ‘mini-prep’ method, the harvested cells were resuspended into 100 µL of the lysis 
buffer [25 mM Tris-HCl (pH 8.0), 50 mM glucose, and 10 mM EDTA]. Then, 200 µL of a 
freshly prepared alkaline solution [0.2 N NaOH, and 1% SDS] was added and mixed with the 
cell lysis solution. The mixture was incubated on ice for 5 min and then neutralized by adding 
150 µL of neutralization solution [3 M potassium acetate], so that the plasmid DNA could be 
separated from the other cell components. After centrifugation of the mixture at 11 000 ×g for 10 
min, the supernatant contained plasmid DNA whereas the cell debris precipitated. The plasmid 
DNA was extracted by adding an equal volume of a phenol:chloroform:isoamyl alcohol 
(25:24:1) solution. The mixture was vortexed and centrifuged at 12 000 ×g for 2 min. The upper 
aqueous layer was carefully transferred to a fresh tube. A two volume of ice-cold 95% ethanol 
was added to the supernatant and the plasmid DNA was precipitated by flash cooling the mixture 
at -80 °C. The plasmid DNA was then washed twice with 70% ethanol and dried at room 
temperature. The dried plasmid DNA was re-suspended into TE buffer [10 mM Tris-HCl (pH 
8.0) and 1 mM EDTA] containing 20 µg mL-1 RNase. 
     The Wizard® Plus SV Minipreps DNA purification kit (Promega) was used, in which all 
solutions and spin columns were provided. The harvested cells were resuspended and lysed in 
cell re-suspension and lysis solutions, respectively. Then, alkaline phosphatase was added and 
the mixture was incubated at room temperature for 5 min. After adding the neutralization 
solution, the mixture was centrifuged at 10 000 ×g for 10 min. The supernatant was carefully 
applied to a spin column. The plasmid DNA bound to the membrane of the spin column, so that 
only plasmid DNA was eluted with nuclease-free water after washing the column with ethanol. 
The purified plasmid DNA was stored at -80 °C. 
 
2.6.1.2 Polymerase chain reaction (PCR) 
     The cloning of the icd gene into an E. coli expression vector is schematically illustrated in 
Figure 2.4. Two primers, named as IDH-U, 5′d(CAGCCAAGGGAATTCATGGCTAAG) and 
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IDH-D, 5′d(CCTTGTCGACGTCGACGCTGAGTG), were designed to newly introduce EcoRI 
and SalI sites at amino- and carboxy-termini of the coding region for C. glutamicum IDH (the icd 
gene). These primers were synthesized by Dr. F. Georges laboratory of the Plant Biotechnology 
Institute (PBI), Saskatoon, Saskatchewan. The coding regions were amplified by the polymerase 
chain reaction (PCR) using pEKicdES1 (a generous gift from J. Eikmanns at Universität Ulm, 
Germany) as a template. Fifty µL of the PCR mixture containing 800 ng of template DNA 
(pEKicdES1), 0.2 µmol of each primer, 0.2 mM dNTPs mix, 5 units of NovaTaqTM DNA 
polymerase and 1× PCR buffer containing 1.5 mM MgCl2 (Novagen) was carried for 30 thermal 
cycles. Each thermal cycle involved denaturation at 94 ºC for 1 min, annealing at 53 ºC for 1 min 
40 s, and polymerization at 71 ºC for 2.5 min. An extra denaturation at 94 ºC for 3 min and 
polymerization at 71 ºC for 3 min was added to initiate and terminate the thermal cycles, 
respectively. The PCR product was obtained through phenol:chloroform:isoamyl alcohol 
extraction followed by ethanol precipitation previously described. The isolated PCR product was 
digested with EcoRI and SalI restriction enzymes and run on 1% agarose gel. The digested DNA 
with the corresponding size was excised from the gel and extracted using Quantum PrepTM Freez 
‘N Squeeze DNA gel extraction spin column (Bio-Rad Laboratory).  
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Figure 2.4 Schematic illustration of cloning the icd gene into an E. coli expression vector. 
     The icd gene was amplified from the template plasmid (pEK-icdES) using the upstream 
(IDH-U) and downstream (IDH-D) primers. The PCR created two restriction enzyme cleavage 
sites (EcoRI and SalI). The amplified gene was inserted into the pGEX6p1 protein expression 
vector that consists of an origin (ori), a LacIq gene (lac Iq), a taq promoter (Ptac), a GST tag 
(glutathione S-transferase), and an ampicillin resistance gene (Ampr).  
 
2.6.1.3 Ligation of the icd gene into the plasmid vector 
Using the extracted DNA insert, the ligation mixture containing the isolated DNA insert, 
the pre-digested E. coli expression vector (pGEX6p1), 0.2 mM ATP, 1 mM DTT, 1× reaction 
buffer and 4 units of T4 DNA ligase (Novagene) was incubated at 12 ºC overnight. Then, 2 µL 
of the ligation mixture was added to 100 µL of E. coli DH5α competent cells and chilled on ice 
for 30 min. Heat-shock was applied to the transformed cells at 42 ºC for 1 min, followed by 
cooling on ice for 2 min. To the cell mixture, 400 µL of LB media was added, and the cells were 
incubated at 37 ºC for one hour (out-growth). The out-grown cells were plated on LB-agar plates 
containing 100 µg mL-1 ampicillin and incubated at 37 ºC overnight.  The colonies were 
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inoculated into 5 mL of LB media at 37 ºC overnight, and the ligated plasmid DNA was isolated 
using Wizard® Plus SV Minipreps DNA purification kit (Promega). The constructed plasmid 
was sequenced at PBI using a Stretch DNA sequencer (Applied Biosystems), to confirm the 
insertion of the icd gene in the proper reading frame. 
 
2.6.2 Site-directed mutagenesis 
     Site-directed mutagenesis was performed using the Quickchange® site-directed mutagenesis 
kit (Stratagene). Three CgIDH mutants were designed based on previous studies on dimeric 
NADP+-dependent IDH mutants and the partial sequence alignments obtained from 
crystallographic structures. The analogous residues, Ser113, Lys253, and Tyr416 were altered to 
aspartic acid, glutamine, and threonine, respectively. The pairs of oligonucleotide primers used 
to generate each of these three mutants are listed in Table 2.5. These mutagenic primers were 
synthesized by Dr. F. Georges laboratory of the PBI, Saskatoon, Saskatchewan.  
     Using each pair of oligonucleotide primers, PCR was carried out in a 50 µL reaction mixture 
containing 100 ng of 7.3 kb template DNA (pGEX6p1-icd), 250 ng of each oligonucleotide, 0.25 
mM dNTPs mixture, 2.5 units of Pfu TurboTM DNA polymerase and 1× reaction buffer  
(Stratagene). Denaturation, annealing, and polymerization were performed at 95 ºC for 50 sec, 60 
ºC for 1 min, and 68 ºC for 10 min, respectively, for 18 cycles. Each reaction was initiated with 
an additional denaturation at 95 ºC for 1min and was terminated at 68 ºC for 7 min after the 
above 18 cycles of the reaction were completed. The reaction mixture was incubated at 37 ºC for 
one hour after adding 10 units of Dpn I in order to digest the methylated, template DNA. Then, 2 
µL of the Dpn I digested DNA was transformed into 100 µL of E. coli XL1-Blue supercompetent 
cells by the heat-shock method described above. The outgrown cells were plated and grown on 
LB agar plates containing 100 µg mL-1 ampicillin. Colonies were sub-cultured and the plasmid 
DNA was isolated using the Promega Wizard plasmid DNA purification kit described above. 
These mutants were sequenced at DNA Technologies Unit NRC-PBI using the sequence primer 
provided from Amersham Biosciences Pharmacia to confirm the successful mutations. 
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CgIDH 
mutant 
Oligonucleotide primer pairs Tm 
(°C) 
Ser130Asp U; 5'd(GCAGCACTGGGTTCACAGCGTCACCCTTAACAGC)3' 
D; 5'd(GCTGTTAAGGGTGACGCTGTGAACCCAGTGCTGC)3' 
79.8 
Lys253Gln U; 5'd(CATCATGGTGGCCTGCAGGTGTGCGGAG)3' 
D; 5'd(CTCCGCACACCTGCAGGCCACCATGATG)3' 
80.2 
Tyr416Thr U; 5'd(GGTCTTGTCATGGGAGCCGGTCTCTTCAGCCTTC)3' 
D; 5'd(GAAGGCTGAAGAGACCGGCTCCCATGACAAGACC)3' 
79.9 
Table 2.5 List of oligonucleotide primer pairs used to generate CgIDH mutants. 
     Each pair of oligonucleotides (U = Upstream; D = downstream) is designed to alter the 
minimum number of nucleotides to generate the desired mutant. The underlined nucleotides are 
those that were changed to create the mutated residue. The melting temperature (Tm) was 
calculated by;  
               Tm= 81.5+0.41 (% GC)- 675/N –(% mismatch)  
where % GC is the percentage of GC bases, N refers to the primer length in bases, and % 
mismatch is calculated simply by (changed bases/ total bases) multiplied by 100 (Nelson and 
McClelland, 1992). 
 
2.6.3 Purification of CgIDH mutants 
2.6.3.1 Protein overexpression 
     The plasmid containing the icd gene mutant was transformed as described above into either 
100 µL of E. coli icd- strain EB106 or BL21 competent cells. The transformed cells were 
streaked on an LB agar plate containing 100 µg mL-1 ampicillin and were incubated at 37 ˚C 
overnight. A single colony was inoculated into 3 mL of LB medium with ampicillin (100 µg mL-
1) and shaken at 37 ˚C overnight. The grown culture was then transferred to 200 mL of LB 
medium containing 1% glucose and ampicillin (100 µg mL-1) and was further incubated at 28 ˚C. 
When absorbance of the culture reached at OD600 = 0.4-0.6, 0.25 mM IPTG was added to induce 
bacterial growth overnight at 28 ˚C. The cells were harvested by centrifugation at 6 000 ×g for 
20 min. 
 
2.6.3.2 Affinity chromatography purification 
     The wet cell pellet was resuspended in 4 mL of ice-cold 1× PBS buffer [2.7 mM KCl, 10mM 
Na2HPO4, 1.8 mM KH2PO4, and 140 mM NaCl (pH 7.3)] and was sonicated at 50 W (5× 1 min 
bursts with 6 min intervals). The cell homogenate was centrifuged at 12 000 ×g for 20 min. The 
sonication and centrifugation were repeated two more times. The supernatant (crude extract) 
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after each centrifugation was transferred to fresh tubes and expression levels of the GST-fused 
IDH mutants were examined on SDS-PAGE gel. After addition of 5 mM DTT, the crude extract 
was loaded onto a pre-equilibrated glutathione Sepharose 4B column (Amersham Biosciences) 
with 1× PBS buffer. The column was washed twice with 10× bed volume of Buffer B [50 mM 
Tris-HCl (pH7.0), 0.15 M NaCl, and 1mM DTT].  Then, PreScissionTM protease diluted 1:25 
with Buffer B was applied to the column and incubated at 4 ˚C overnight in order to cleave the 
GST tag. The enzyme was eluted with Buffer B, followed by glutathione elution Buffer C [10 
mM reduced glutathione, 50 mM Tris-HCl (pH 8.0) and 1 mM DTT]. Protein purity at each step 
was checked by SDS-PAGE. 
 
2.6.3.3 Mass spectrometry (MS) 
     Mass spectrometry (MS) is used to measure the molecular mass of a compound. MS studies 
for the purified IDH mutants were performed at the PBI by Doug Olson. The protein molecular 
weight was determined by linear MALDI-TOF MS.  A protein solution containing 
approximately 10 pico-moles of protein was mixed 1:1 with sinapinic acid as the matrix. The 
matrix was made up at 20 mgs/ml in 70% acetonitrile and calibrated wit bovine serum albumin. 
 
 
2.7 Kinetic assays of wild-type and mutant CgIDH 
     The kinetic characteristics of an enzyme can be determined if the absorbance of an assay 
solution changes as a substrate is converted into the product by enzyme catalysis. When either 
the substrate or the product of a catalytic reaction absorbs light of a certain wavelength, the 
change in the absorbance monitored is related to the rate of catalysis. The rate of catalysis is 
equivalent to the change in absorbance over the time-course of the reaction, as in the calculation 
below (Formula 2.6): 
                  Formula 2.6 
where (∆A/min) is the change in absorbance per min, and ε is the extinction coefficient for the 
product in the assay system. One µmol of product formed per mg of enzyme per minute is 
termed the specific activity of the enzyme and is calculated by: 
Specific Activity = Rate/ [mg of protein used in the assay]  
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Enzyme assays were performed at room temperature using an Ultraspec 2100 pro 
UV/visible spectrophotometer and the application software, SWIFTII-Methods (Amersham 
Biosciences). The 1-ml assay solution consisted of 87.4 mM triethanolamine buffer (TEA) pH 
7.6, 0.8 mM MnSO4, 1.0 mM isocitrate and 0.5 mM NADP+, unless specific conditions were 
mentioned (Bai et al., 1999). The Km values for isocitrate and NADP+ have been reported as 5 
µM and 4 µM, respectively (Chen and Yang, 2000). For activity assays of wild-type CgIDH, 
about 1-2 µg of enzyme was used, whereas ~100 µg of the CgIDH mutants were required to 
examine their activities. A unit of activity is defined as 1 mmol of NADPH formed per minute 
while ε for NADPH is 6220 M-1 cm-1. Absorbance at 340 nm increased as NADP+ was changed 
into NADPH by CgIDH catalysis, as shown in Figure 2.5. 
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Figure 2.5 A typical plot for CgIDH activity. 
     The absorbance at 340 nm was increased over a time-course as NADP+ was converted to 
NADPH by CgIDH catalysis. About 1.5 µg of CgIDH was used to obtain its catalytic activity.  
 
 
2.8 Fluorescence spectroscopic studies on CgIDH 
     Fluorescence is the property of certain molecules (known as fluorophores) to absorb light at 
one wavelength and emit light at a longer wavelength (reviewed in Eftink and Shastry, 1997). 
When a fluorophore absorbs light energy, it is usually excited to a higher vibrational energy level 
in the excited state (Figure 2.6). The subsequent rapid relaxation to the lowest vibrational energy 
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level is termed internal conversion (IC) and occurs in a pico-second or less. IC is the 
radiationless transition (heat) between energy levels of the same spin state. If the photon 
emission occurs between the same spin states, this radiative process is called fluorescence. Due 
to the relaxation of energy in the excited state, the detected fluorescence emission has lower 
energy than the detected absorption. This difference in energy between fluorescence and 
absorption is called the Stokes shift. 
     Three aromatic amino acid residues in proteins, Trp, Tyr and Phe, have distinct absorption 
and emission wavelengths and can contribute to the intrinsic fluorescence of a protein. The 
dominant intrinsic fluorophore, Trp, has much stronger fluorescence and higher quantum yield 
than the other two aromatic amino acid residues. Its fluorescence can be selectively excited at 
295-305 nm and can be observed at 330-350 nm. Trp fluorescence is very sensitive to its local 
environment. Typically, Trp residues that are exposed to water, have maximal fluorescence at a 
wavelength of about 340-350 nm, whereas for totally buried Trp residues fluorescence occurs at 
about 330 nm. Any changes in fluorescence emission spectra of a protein are related to a 
conformational change, a subunit association, substrate binding, denaturation, or anything that 
affects the local environment surrounding the indole ring of the Trp residue. Also, Trp appears to 
be uniquely sensitive to collisional quenching, either by externally added quenchers such as 
acrylamide, or by neighboring protonated acidic groups such as Asp or Glu in the protein. Hence, 
fluorescence spectroscopy is a useful technique to monitor the local side chain environment and 
dynamics of a protein in solution (reviewed in Eftink and Shastry, 1997). 
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Figure 2.6 A Jablonski diagram describing absorption and emission of light. 
Fluorescence activity can be schematically illustrated with a Jablonski diagram, which 
describes how electrons in fluorophores are excited from the ground state (S0) into higher 
electronic energy states (S1, S2, and Sn), and then how these excited molecules emit photons and 
fall back into lower energy states. Modified from website: 
http://www.shsu.edu/~chemistry/chemiluminescence/JABLON.GIF 
 
     Prior to fluorescence spectroscopic studies, absorption spectra studies were conducted using 
the Ultraspec 2100 pro UV/Visible spectrophotometer (Amersham Bioscience), in order to verify 
the presence of an interaction between CgIDH and its substrate(s) before excitation. Interactions 
between CgIDH and its substrate(s) before excitation can be monitored by any changes in the 
absorption spectra. The absorption spectrum for CgIDH was observed between 250 nm to 500 
nm before and after adding its substrate(s). 
     In this research, fluorescence spectroscopic studies were performed at room temperature 
using the fluorescence spectrometer F-2500 (Hitachi). A KAC buffer [25 mM 3-[N-morpholino] 
propane sulfonic acid (MOPS) pH 7.3, 5 mM MgCl2, 100 mM NaCl and 1mM DTT] was used as 
a dilution and a reference buffer. Setting excitation wavelength at 297 nm with 10 nm excitation 
emission slits, fluorescence spectra were measured at 310-550 nm. No fluorescence was 
observed by the KAC buffer, isocitrate or NADP+ by itself at 250-350 nm. The changes in 
maximum fluorescence emission from Trp residues within the protein in the absence and 
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presence of the substrate(s) were recorded. About 30-50 µg mL-1 of protein was used to obtain 
the fluorescence spectra.  
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Chapter 3 Results 
3.1 Modified purification of monomeric IDH from C. glutamicum 
For protein crystallization, typically a protein purity of 95 % or higher is recommended. 
In order to achieve such high purity, an effective protein purification strategy uses a minimum 
number of steps. Monomeric IDH from C. glutamicum (CgIDH) was previously purified with 
three different chromatography steps after sonication and ammonium sulfate fractionation. 
Among these chromatography steps, gel filtration was the least effective because of the lowest 
purity improvement (Bai et al., 1999). The anion exchange step with Mono Q HR 10/10 
appeared to give the highest purity. This step, however, was difficult and time-consuming since 
concentration of the pooled protein fractions was required before applying to the column and it 
required desalting of the collected protein fractions after passing through the column. Affinity 
chromatography, on the other hand, was the most specific and quick method for CgIDH 
purification since only NADP+-dependent proteins bind to this column. Therefore, gel filtration 
and anion-exchange chromatography were omitted after ammonium sulfate fractionation. 
Ammonium sulfate fractionation was an important step to reduce the volume of crude extract 
from the repeated sonication so that an adequate volume of protein solution could be applied to 
the affinity column. The purity from this two-step purification method was still close to 95% 
according to SDS-PAGE (Figure 3.1), and CgIDH crystals were successfully obtained after 
using this protein purification strategy. 
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Figure 3.1 SDS-PAGE of CgIDH. 
Proteins are stained with Coomassie Blue on the 8% SDS-PAGE. The molecular mass 
marker (MW) is at the left-end. Approximately 5 µg of protein solution was loaded per lane. 
Lane 1 for crude extract, Lane 2 for protein solution after the ammonium sulfate fractionation, 
and Lane 3 for purified CgIDH after Red Sepharose CL-6B affinity chromatography. The 
approximate molecular mass of CgIDH is 80 kDa as indicated. 
 
 
3.2 Crystallization 
3.2.1 Crystallization in the absence and presence of substrate(s) 
Purified CgIDH at a concentration of 5 mg ml-1 was crystallized by the hanging-drop 
vapour diffusion method at room temperature under the conditions previously described 
(Audette et al., 1999). Although an IDH crystal with 0.3 × 0.1 × 0.05 mm dimensions was 
obtained within a week (Figure 3.2A), the crystal spontaneously started cracking soon after it 
was exposed to air or several weeks after it appeared (Figure 3.2B).  
    From the additive screening trials, some additives such as sucrose, glucose, MPD, and 
ethylene glycol seemed to improve crystal stability (Figure 3.2C) while most inorganic ions had 
less effect on crystallization. The presence of a substrate (isocitrate or NADP+) or an inhibitor 
(e.g. malate) could stabilize crystals but usually produced a cluster of crystals (Figure 3.2D). 
Lower concentrations of protein reduced crystal growth rate but a single crystal was only 
occasionally obtained after a year (Figure 3.2E).  
In addition to vapour diffusion crystallization, direct interface crystallization in a 
capillary using agarose gel or Silica Hydrogel was attempted. The problems with this method, 
however, were the difficulties to observe crystals in a glass capillary and to mount one on the 
goniometer head for diffraction. Therefore, either successful additives or lower protein 
concentrations 3-5 mg mL-1 were used to produce crystals of consistent quality. 
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(A)
 
(B)
 
 
(C)  (D) 
(E) 
Figure 3.2 CgIDH crystals.  
      (A) A single crystal of CgIDH complexed with Mg2+ was obtained under the conditions 
previously described (Audette et al., 1999). (B) The crystal cracked after a few weeks or when it 
was exposed to the air. (C) A single CgIDH crystal obtained with 6 % sucrose as an additive. 
(D) Clusters of CgIDH crystals complexed with NAD+ obtained under the same conditions as 
(A) but with 2.5 mM NAD+. (E) A single CgIDH crystal obtained from a lower concentration of 
protein after crystallization for a year. 
 
3.2.2 Cryo-crystallography 
Various cryoprotectants were prepared and examined by a flash cooling method in order to 
optimize the cryocrystallographic conditions for successful diffraction data collection from 
CgIDH crystals. The challenge was that, to date, no CgIDH crystal had given diffraction data 
better than 3.0 Å resolution nor acceptable crystal mosaicity. High crystal mosaicity makes it 
difficult to distinguish the diffraction spots from background noise, and thus to determine 
reflection intensities from which the structure factors are calculated. Due to high crystal 
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mosaicity, the preliminary diffraction data sets for CgIDH were not accurate enough to solve the 
structure. It is not unusual for a protein crystal to diffract poorly due to non-optimal cryo 
conditions. The first AvIDH structure was, indeed, solved after growing the crystal in the 
presence of 20 % (v/v) glycerol and then flash cooling the crystal under a nitrogen stream just 
prior to diffraction, because earlier cryoprotectant trials were unsuccessful (Yasutake et al., 
2002). For CgIDH crystals, however, optimization of the cryoprotectant was definitely required 
since it had to be frozen prior to shipping to a synchrotron.  
After many trial-and-error attempts, a CgIDH crystal complexed with Mg2+ successfully 
diffracted to 1.75 Å resolution. Rather than one single cryoprotectant, a combination of two 
cryoprotectants, as well as a combination of a cryoprotectant and light paraffin oil appeared to 
work synergistically to achieve successful diffraction. Covering the crystal-containing droplet 
with oil prevented cracking of the crystal when exposed to the air. The use of a slightly smaller 
loop for mounting a crystal also minimized the volume of cryoprotectant covering the crystal. 
The successful cryocrystallographic conditions and diffraction results are summarized in Table 
3.1 and support the idea that a combination of a cryoprotectant with light paraffin oil and a 
combination of two cryoprotectants most likely worked synergistically to improve resolution 
and lower crystal mosaicity. 
 
 
 
 
 
 
 
 
Cryoprotectant(s) 
Oil 
treatment 
Diffraction 
resolution limit (Å) 
20 % MPD No 3.0-3.5 
15 % Glycerol Yes 2.0 
30 % Glycerol No 3.0 
30 % Glycerol Yes 2.2-2.4 
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10 % MPD and 20 % Glycerol No 4.0 
10 % MPD and 20 % Glycerol Yes 2.2 
15 % MPD and 10 % Glycerol No 1.8 
15 % MPD and 15 % Glycerol  No 2.3-2.6 
A serial soaking of 15 %, 20 % and 30% Glycerol No 3.0 
A serial soaking of 20 % and 30% Glycerol No 3.0-5.0 
A serial soaking of 20 % and 30% Glycerol Yes 1.7-2.3 
Table 3.1 Effects of different cryoprotectants and of light paraffin oil on the Mg2+-complex of 
CgIDH crystal diffraction. 
    Oil treatment refers to the condition where light paraffin oil was used to cover the crystal-
containing droplet during soaking the crystal in cryoprotectant, to prevent exposure to the air. 
Diffraction resolution limits were obtained from one to three images of each previously frozen 
crystal at the APS. 
 
 
3.3 The structure of CgIDH in complex with Mg2+ 
3.3.1 Quality of the final structure 
The structure of CgIDH in complex with Mg2+ was solved and refined to a resolution of 
1.75 Å. There are four symmetry related CgIDH molecules well packed in the unit cell (Figure 
3.3). Each molecule of CgIDH in the refined crystal structure consists of 735 amino acid 
residues (of a total of 738 in the CgIDH sequence). Electron density was not observed for the 
first N-terminal residue and for the last two C-terminal residues. There are 235 water molecules 
refined in the final structure. One divalent metal ion, Mg2+, was observed adjacent to Asp346. 
The structure was analyzed by the program PROCHECK from the CCP4 package (Laskowski et 
al., 1993; CCP4, 1994). The final Rcrys and Rfree values were 0.226 and 0.245, respectively. The 
average B factors for protein atoms, water molecules, and Mg2+ were 30.7 Å2, 29.4 Å2, and 18.5 
Å2, respectively; the overall average B factor was 30.4 Å2. A total of 91% of the residues in the 
CgIDH structure were within the most favoured region of the Ramachandran plot (Figure 3.4) 
(Ramakrishnan and Ramachandran, 1965). Both Glu13 (φ = 39 and ψ = -124) and Glu418 (φ = 
53 and ψ = -136) were in the generously-allowed region but were in excellent density in the 
2Fo-Fc map, confirming the validity of their unusual dihedral angles. The mean coordinate 
error from the Luzatti plot analysis was 0.24 Å (Luzatti, 1952). The final refinement statistics 
are summarized in Table 3.2. 
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Figure 3.3 Packing of CgIDH molecules in its unit cell. 
     Four symmetrically related monomeric IDH molecules were packed well within its unit cell. 
Each equivalent molecule of CgIDH is drawn in different coloured ribbon. This picture was 
produced from Setor (Evans, 1993).  
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Figure 3.4 Ramachandran plot for the structure of CgIDH complexed with Mg2+. 
   Every square represents a non-glycine residue in the CgIDH molecule; each triangle is a 
glycine residue. The red colored region is the most favoured region in the Ramachandran plot 
(Ramakrishnan and Ramachandran, 1965). The yellow and light-yellow colored areas are the 
additional and generously allowed regions, respectively. The disallowed region is white. Two 
red squares labeled as Glu13 and Glu418 are in generously allowed region in the plot, but in the 
structure, these residues lie in well-defined electron density. The regions labeled as a/~a, b/~b, 
l/~l, and p/~p correspond to the right-handed α-helices, β-strands, left-handed α-helices, and 
turns of the structure of a protein, respectively.  
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Resolution limits (Å ) 15-1.75 
(1.82-1.75) 
No. of reflections 75896 
(6563) 
R cryst 0.226 
(0.322) 
R free 0.245 
(0.322) 
No. of  residues 735 
No. non-hydrogen atoms 5868 
No. water molecules 235 
Overall B factor (Å 2) 30.4 
Average B factor for protein atoms (Å 2) 30.7 
Average B factor for water molecules (Å 2) 29.4 
R.m.s.d. from ideal geometry 
Bond distances (Å) 
Bond angles (˚) 
Dihedral angles (˚) 
Improper angles (˚) 
 
0.005 
1.276 
21.93 
0.856 
Ramachandran plot regions 
Residues in most favored regions (%) 
Residues in additional allowed regions (%) 
Residues in generously allowed regions (%) 
Residues in disallowed regions (%) 
 
91.7 
8.0 
0.3 
0.0 
Table 3.2 Summary of the refinement statistics for a crystal of CgIDH complexed with Mg2+. 
     The quality of the structure of CgIDH complexed with Mg2+ was tested with PROCHECK 
from the CCP4 package after its final refinement (Laskowski et al., 1993; CCP4, 1994). The 
Rcrys and Rfree were calculated from Formulas 2.3 and 2.4 described in Materials and Methods 
(Page 48). The values in brackets are those for the highest resolution shell. 
 
     3.3.2 Overall structural description 
The structure of CgIDH complexed with Mg2+consists of two distinct domains like the 
other monomeric AvIDH structures (Figure 3.5) (Yasutake et al., 2002, 2003). The relatively 
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small domain (Domain I) is formed from 316 amino acid residues from both the N- and C- 
termini; the larger domain (Domain II) is composed of 422 residues. A cleft region was 
observed between these two domains and is expected to form the active site as in the other 
monomeric IDH enzymes. There are 14 α-helices and 6 β-strands in Domain I, and 14 α-helices 
and 16 β-strands in Domain II. A pseudo 2-fold axis was present only in Domain II, which is 
analogous to the crystallographic 2-fold axis in the homodimeric IDH structures (Figure 3.6). 
The equivalent topology to the clasp region that inter-locks two subunits in homodimeric IDH 
structures is also present in Domain II. All of the residues at the catalytic site that have been 
described in the structures of AvIDH are donated by the two domains of CgIDH in an 
asymmetric manner and are located facing the cleft region (Figure 3.7).  
              
Figure 3.5 Stereo diagram of the overall structure of CgIDH complexed with Mg2+. 
   The structure of CgIDH complexed with Mg2+ is composed of two distinct domains like the 
structure of AvIDH complexed with isocitrate-Mn2+ (Yasutake et al., 2002). The blue ribbons 
represent β–strands; red ribbons are α–helices. Random coils are drawn in black strings, while 
Mg2+ is drawn as a pink sphere and is indicated by an arrow. Domain I and Domain II are 
indicated as I and II, respectively. This figure was produced using Setor. 
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Figure 3.6 Stereo diagram of the pseudo 2-fold axis in Domain II of the structure of CgIDH 
complexed with Mg2+. 
    The pseudo 2-fold axis (line) was observed only in Domain II in the structure of CgIDH 
complexed with Mg2+. This picture was produced from Setor.
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Figure 3.7 Stereo diagram of the active site in the structure of CgIDH complexed with Mg2+. 
     The structure of CgIDH complexed with Mg2+ was superimposed on the structure of AvIDH 
complexed with isocitrate-Mn2+. The backbone for the structure of AvIDH complexed with 
isocitrate-Mn2+ is not shown, but the active site residues are drawn in blue sticks. The equivalent 
active site residues in CgIDH to the structure of AvIDH complexed with isocitrate-Mn2+ are 
located at the cleft region between the two domains in the structure. The gray ribbons represent 
the backbone of CgIDH, while the equivalent active site residues are drawn in red sticks. 
Isocitrate and Mn2+ in the structure of the complex of AvIDH are drawn in yellow sticks and as a 
yellow sphere, respectively. This picture was produced from Setor. 
 
3.3.3 Coordinates of Mg2+ at the active site 
NADP+-dependent IDH requires a divalent ion for catalysis. Magnesium chloride was 
added for the crystallization of CgIDH, and it was highly expected that bound Mg2+ would be 
found in the structure. One Mg2+ was indeed observed adjacent to Asp346 at the active site in the 
structure. This cation is coordinated in an octahedral geometry by Asp346 Oδ1, Asp544 Oδ2, 
Asp548 Oδ1, the carbonyl group of Asp544, and two water molecules (Figure 3.8). The bond 
distances for each atom to the ion are summarized in Table 3.3. The overall average coordinating 
distance is 2.22 Å. According to the geometrical data of metal-ligand interaction (Harding, 2001, 
2004), the coordination number for Mg2+ is commonly six and the average metal-ligand distance 
is 2.26 Å when a metal is coordinated by carboxylates of Asp or Glu (Harding, 2001). Bound 
Mg2+ in the structure of CgIDH complexed with Mg2+ agreed with this accepted value, 
confirming the bound metal is magnesium ion.  
           
Figure 3.8 Stereo diagram of the coordinating geometry of Mg2+ in the CgIDH structure. 
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Three Asp residues (red) and two water molecules (blue spheres) coordinate Mg2+ (pink 
sphere) in an octahedral manner. The coordinating atoms are connected by dashed lines toward 
Mg2+. 
 
Coordinating atom Distance from the 
Mg2+ ion (Å) 
Asp346 Oδ1 2.20 
Asp544 O 2.21 
Asp544 Oδ2 2.17 
Asp548 Oδ1 2.18 
WAT 1031 O 2.27 
WAT 1157 O 2.31 
Table 3.3 The coordination distances of atoms with Mg2+. 
   The distances were obtained from the NEIGHBOURS function on the TURBO-FRODO 
(Roussell et al., 1990). 
 
 
3.4 Site-directed mutagenesis studies on CgIDH 
3.4.1 Purification of the S130D, K253Q, and Y416T CgIDH mutant proteins 
Three CgIDH mutants, S130D, K253Q, and Y416T were successfully created and 
confirmed by DNA sequencing. When the pGEX6p1-icd plasmid containing each CgIDH mutant 
was transformed into either E. coli EB106 strain (icd- strain) or BL21 strain, all the mutants were 
successfully transformed and overexpressed with 0.2 mM IPTG, except the Y416T mutant which 
could only be purified from the BL21 strain. Since these mutants were expressed with a GST-
tag, the GST-tag fused CgIDH could be purified to homogeneity by one-step affinity 
chromatography while the endogenous E. coli dimeric IDH, which lacked the tag, could be 
excluded. Hence, all the CgIDH mutants were expressed in E. coli BL21 rather than in EB106, in 
order to apply a consistent purification method for all the mutants. GST-tag free CgIDH mutant 
was purified using glutathione Sepharose 4B chromatography and the on-column cleavage of the 
GST-tag with PreScissionTM protease (Figure 3.9). It should be noted that the specific activity of 
the CgIDH mutants could only be measured after their purification because of the presence of 
endogenous E. coli dimeric IDH in the crude extract, which catalyzes the same assay reaction. 
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The GST-tag also appeared to interfere with CgIDH activity, so only SDS-PAGE could be used 
to verify the purification progress for these mutants.   
From SDS-PAGE, it was estimated that the purity of each mutant was approximately 90% 
(Figure 3.10). Each mutant was further tested by MS analysis to determine the precise molecular 
mass of each mutant. 
 
 
 
Figure 3.9 SDS-PAGE of the Y416T CgIDH mutant from E. coli BL21. 
     The GST-tag fused Y416T CgIDH mutant with its molecular mass of about 110 kDa was 
over-expressed in E. coli BL21 cells and was purified by affinity chromatography. Lane 1 for 
crude extract, and Lane 2 for purified CgIDH mutant after glutathione Sepharose 4B affinity 
chromatography and removal of GST-tag. The approximate molecular mass of this CgIDH 
mutant is 80 kDa after the GST-tag was cleaved. Approximately 5 µg of protein solution per lane 
was run on an 8% SDS-PAGE.  
 
 86
87 
 
Figure 3.10 SDS-PAGE of three CgIDH mutants.  
     The three purified CgIDH mutants (~5 µg per lane) were run on a 6% SDS-PAGE. Lane 1 for 
wild-type IDH, Lane 2 for the S130D mutant, Lane 3 for the K253Q mutant and Lane 4 for the 
Y416T mutant. The approximate estimated molecular mass of each CgIDH mutant is ~83 kDa as 
indicated. 
 
3.4.2 Specific activities of the CgIDH mutants 
Enzymatic activity of the newly created and purified CgIDH mutants were tested as 
described in Materials and Methods, except that TEA buffer was replaced by Buffer A [25mM 
MES (pH 6.2), 2.5 mM MnSO4 and 1mM DTT]. All of the three mutants, S130D, K253Q, and 
Y416T CgIDH mutants, exhibited much lower specific activities than did wild-type CgIDH. The 
S130D mutant exhibited ~7% of the wild type; the catalytic activity for the K253Q and Y416T 
mutants was not detectable. 
Ser130 in CgIDH, equivalent to the catalytically important serine (Ser113) in EcIDH, is 
located at an equivalent position in the active site of the structure of CgIDH. Ser113 in EcIDH 
interacts with the oxygen atom linked to C5 of isocitrate as well as did the equivalent serine 
residue in AvIDH. The substitution of the phosphoserine Ser113 with a negatively charged 
residue inactivated EcIDH. Because of the highly conserved active site between monomeric and 
homodimeric IDH structures, mutating this serine residue to a negatively charged residue, Asp or 
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Glu, might be expected to interrupt the interaction of CgIDH with isocitrate, resulting in reduced 
catalytic activity or even inactivation of CgIDH (LaPorte, 1993; Yasutake et al., 2002). Kinetic 
assays of the S130D CgIDH mutant revealed that the replacement of this Ser130 residue by a 
negatively-charged amino acid, Asp, did not completely inactivate CgIDH even though it 
resulted in ~7% specific activity relative to the wild-type. A significant reduction of the specific 
activity in the S130D CgIDH mutant still indicates that the serine at position 130 may have an 
important role in CgIDH activity.  
     Due to the fact that the C. glutamiucm AT13032 genome sequence has recently been 
reported (Kalinowski et al., 2003), a search was performed of the C. glutamicum genome for the 
equivalent enzyme to E. coli IDHK/P to verify whether an enzyme for the phosphorylation of 
CgIDH was present or not. No possible gene or protein homologous to the E. coli IDHK/P was 
found in the database using the BLAST search engine (Altschul et al., 1990, 1994). Taken 
together, with the reduction of the specific activity in the S130D CgIDH mutant, it is presumed 
that Ser130 may be required for catalysis but may not be regulated by 
phosphorylation/dephosphorylation to inactivate/activate CgIDH. 
Residues analogous to Lys253 and Tyr416 in CgIDH have been reported to play critical 
roles in PmIDH catalysis since PmIDH activity was reduced by more than 100-fold when 
analogous Lys and Tyr residues were replaced by Gln or Thr, respectively (Kim et al., 2003). In 
the structure of AvIDH complexed with isocitrate-Mn2+, the equivalent residues were located at 
the catalytic site and formed hydrogen bonds with isocitrate (Yasutake et al., 2002). When the 
Lys253 in CgIDH was mutated to Met, catalytic activity was not detected (Chen and Yang, 
2000). From the amino acid sequence alignment, furthermore, this Lys253 in CgIDH is 
completely conserved among both homodimeric and monomeric NADP+-dependent IDH 
enzymes, whereas the Tyr416 is conserved only among NADP+-dependent monomeric IDH 
enzymes (Figure 3.11). Specific activities for the K253Q and Y416T CgIDH mutants was not 
detectable, indicating that Lys253 and Tyr416 may be essential for CgIDH activity or may play a 
critical role in the regulation of its activity. 
 
 
 
CgIDH 123 RYNAVKGSAVNPVLR----EGNSDRRAPIAVKNFVKKFPHRMGEWSADSK-TNVATMDAN 177              
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AvIDH 125 RYDKIKGSAVNPVLR----EGNSDRRAPLSVKNYARKHPHKMGAWSADSK-SHVAHMDNG 189 
PmIDH   88 KLKKMWKSP-NGTIRNILGGTVF-REPIICKNIPRLVPGWTKPITIGRH-AHGDQYKATD 144 
HcIDH   87 KLKQMWKSP-NGTIRNILGGTVF-REAIICKNIPRLVSGWVKPIIIGRH-AYGDQYRATD 143 
EcIDH   94 PVGGGIRSL-NVALRQELDLYICLRPVRYYQGTPSPVKHPELTDMVIFRENSEDIYAGIE 164 
                                                        
CgIDH 237 QVARAKA-EGILFSAHLKATMMKVSDPIIFGHVVRAYFADVFAQYGEQLLAAGLNGENGL 295 
AvIDH 239 EIEDAKK-QGVLLSVHLKATMMKVSDPIMFGQIVSEFYKDALTKHAEVLKQIGFDVNNGI 297 
PmIDH 197 CFQYAIQ-KKWPLYMSTKNTILKAYD---------GRFKDIFQEIFEKHYKTDFDKYK-- 244 
HcIDH 196 SFQMALS-KGWPLYLSTKNTILKKYD---------GRFKDIFQEIYDKQYKSQFEAQK-- 243 
EcIDH 213 AIEYAIANDRDSVTLVHKGNIMKFTEG---------AFKDWGYQLAREEFGGELIDGG-- 261 
                           
CgIDH 296 AAILSGLESLDNGE--EIKAAFEKGLEDGPDLAMVNSARGITNLHVPSDVIVDASMPAMI 353 
AVIDH 298 GDLYARIKTLPEAKQKEIEADIQAVYAQRPQLAMVNSDKGITNLHVPSDVIVDASMPAMI 357 
PcIDH 245 --------------------------------------------IWYEHRLIDDMVAQVL 260 
HcIDH 244 --------------------------------------------IWYEHRLIDDMVAQAM 259 
EcIDH 262 -------------------------------PWLKVKNPNTGKEIVIKDVIADAFLQQIL 290 
                                              
CgIDH 413 AEEYGSHDKTFRIEADGVVQVVSSNGDVLIEHDVEANDIWRACQVKDAPIQDWVKLAVTR 472 
AvIDH 417 AEEYGSHDKTFQIPADGVVRVTDESGKLLLEQSVEAGDIWRMCQAKDAPIQDWVKLAVNR 476 
                                                        
CgIDH 533 DTISVTGNVLRDYNTDLFPILELGTSAKMLSVVPLMAGGGLFETGAGGSAPKHVQQVQEE 592 
AvIDH 537 DTISVTGNVLRDYLTDLFPIMELGTSAKMLSIVPLMSGGGLFETGAGGSAPKHVQQFLEE 596 
PmIDH 273 --------YDGDVQSDILAQG-FGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKG 323 
HcIDH 272 --------YDGDVQSDSVAQG-YGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKG 322 
EcIDH 304 --------LNGDYISDALAAQ---VGGIGIAPGANIGDECALFEATHGTAPKYAGQD--- 349 
                          
CgIDH 593 NHLRWDSLGEFLALAESFRHELNNNGNTKAGVLADALDKATEKLLNEEKSPSRKVGEIDN 652 
AvIDH 597 GYLRWDSLGEFLALAASLEHLGNAYKNPKALVLASTLDQATGKILDNNKSPARKVGEIDN 656 
PmIDH 324 RPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQTLEKVCVETVESGAMTKDLAGCIHG 383 
HcIDH 323 QETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKG 382 
EcIDH 350 ---KVNPGSIILSAEMMLRHMG-------WTEAADLIVKGMEGAINAKTVTYDFERLMDG 399 
 
Figure 3.11 Multiple sequence alignments among monomeric and homodimeric IDH enzymes 
from different organisms. 
      Using CLUSTAL W (Higgins et al., 1994), portions of the amino acid sequences of 
monomeric and homodimeric IDH enzymes are aligned and then modified due to the active site 
residues from the structures. The residues at the NADP+-binding site (blue) and at the isocitrate 
and divalent metal cation-binding site (pink) are highlighted. Three residues that have been 
mutated in CgIDH and the equivalent residues are highlighted in red.  
 
3.5 Fluorescence studies to understand the conformational changes in CgIDH 
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   3.5.1 Changes in fluorescence emission for wild type (wt)-CgIDH upon substrate(s) binding. 
Both absorption and fluorescence spectroscopic analyses were conducted to examine if any 
conformational changes can be detected in CgIDH upon its substrate(s) binding. No change in 
the absorption spectrum was observed for wild type (wt)-CgIDH in the absence and presence of 
only either isocitrate or NADP+ (data not shown). The relative fluorescence intensity, however, 
changed when either isocitrate or NADP+ alone was added to the CgIDH solution (Figure 3.12). 
An approximate 31% quenching of the fluorescence emission was induced when NADP+ was 
added, whereas an approximate 15% enhanced fluorescence emission occurred in the presence of 
isocitrate. These changes in the fluorescence emission for wt-CgIDH suggest that a 
conformational change occurs upon binding of the substrate(s). Furthermore, from the 
fluorescence spectra, the wavelength of maximum fluorescence intensity did not shift by more 
than 1-2 nm, indicating that Trp residues in wt-CgIDH were not exposed to water by substrate 
binding. Thus, the fluorescence emission of wt-CgIDH quenched in the presence of NADP+ and 
enhanced in the presence of isocitrate, indicate that binding of either NADP+ or isocitrate to wt-
CgIDH may induce a conformational change which may not involve the exposure of the Trp 
residues to water. 
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Figure 3.12 Changes in the fluorescence emission for wt-CgIDH upon binding of isocitrate or 
NADP+. 
    The relative fluorescence emission was measured from 310 nm to 500 nm after excitation at 
297 nm in the absence (blue) and presence (pink) of (A) 1.2 mM isocitrate or (B) 0.08 mM 
NADP+.  
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Fluorescence intensity decreased at 335 nm and was enhanced at 450nm by gradual addition 
of NADP+ to the protein solution (Figure 3.13). The enhanced fluorescence intensity at 450 nm 
corresponding to the wavelength at which NADP+ fluoresces, increased as more NADP  was 
added. The relative fluorescence emission of wt-CgIDH at ~395 nm did not change regardless of 
the concentrations of NADP
+
+, at which wavelength is termed the isosbestic point (IBP) (Figure 
3.13).  
 
Figure 3.13 The relation between dynamic quenching of wt-CgIDH and the concentration of 
NADP+. 
Wt-CgIDH with no substrates (dark blue) is titrated with NADP+ after adding 0.4 mM 
isocitrate. NADP+ was added step-by-step to its final concentration: 0.02 mM (yellow), 0.04 mM 
(sky blue), 0.06 mM (purple), 0.08 mM (pink), and 0.1 mM (green).  The enhanced fluorescence 
at 460 nm corresponds to the fluorescence from NADPH. The isosbestic point at ~395 nm is 
drawn as a black arrow.  
 
Furthermore, the fluorescence emission of CgIDH was altered regardless of whether 
isocitrate was added before or after adding NADP+ (Figure 3.14). In the presence of NADP+, the 
fluorescence emission of CgIDH at 330 nm was reduced by adding isocitrate, and the 
fluorescence emission at 460 nm (corresponds to the fluorescence of NADP+ and NADPH) was 
increased. These changes in the fluorescence emission indicate not only that the catalytic 
reaction is taking place but also that the conformational changes of CgIDH occur in the presence 
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of both isocitrate and NADP+. From these fluorescence spectroscopic studies, it is suggested that 
the catalytic reaction and the conformational changes could occur in a reversible manner.  
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 Figure 
3.14 The quenching of the fluorescence emission of CgIDH in the presence of NADP+. 
     The fluorescence emission of CgIDH in the absence of both isocitrate and NADP+ was 
compared with the one in the presence of NADP+ (A) before and (B) after adding isocitrate to 
the CgIDH solution. The color codes are; blue for the absence of the substrate(s), pink for the 
presence of (A) 0.02 mM NADP+ or (B) 0.4 mM isocitrate, and yellow for the presence of both 
0.4 mM isocitrate and 0.02 mM NADP+(A and B).   
 
3.5.2 Absorption and fluorescence spectra for CgIDH mutants 
Similar absorption and fluorescence spectroscopy studies were performed for the CgIDH 
mutants in order to examine whether these mutants undergo similar conformational changes 
upon substrate binding. The absorption spectrum of the S130D mutant changed by adding 
NADP+ (Figure 3.15), indicating that this mutant could interact with NADP+. On the other hand, 
unchanged absorption and fluorescence spectra were observed for the same mutant in the 
presence of isocitrate, which indicates that the S130D mutant could not bind isocitrate (data not 
shown). Based on the absorption spectrum, it is presumed that the S130D mutant interacts with 
NADP+ but not with isocitrate. Fluorescence spectroscopic studies also did not indicate that any 
conformational change occurred in CgIDH in the presence of isocitrate. 
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Figure 3.15 Absorption spectra for the S130D CgIDH mutant. 
Absorption by the S130D mutant in the presence of 0.4mM NADP+ (pink) is enhanced 
compared to absorption in the absence of NADP+ (dark blue). Similar absorption spectra 
occurred for the K253Q and Y416T CgIDH mutants. 
 
Similarly, changes in the absorption spectra were observed for the K253Q and Y416T 
mutants upon the addition of NADP+, but not isocitrate. Thus, any changes in the fluorescence 
emission detected in these mutants could not be related to a conformational change upon binding 
of NADP+ since both the K253Q and Y416T mutants interact with NADP+ prior to the excitation 
for the fluorescence. Fluorescence spectroscopic analysis, however, showed that the enhanced 
fluorescence emission for these mutants mediate a conformational change after the addition of 
isocitrate. More enhanced fluorescence was observed with the K253Q mutant than with the 
Y416T mutant, indicating that the K253Q mutant may induce more conformational change than 
does the Y416T mutant in the presence of isocitrate (Figure 3.16). These results suggest that the 
K253Q and Y416T mutants may still allow a conformational change upon binding of isocitrate, 
but not of NADP+.  
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Figure 3.16 Fluorescence spectra for the K253Q and Y416T CgIDH mutants. 
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     The fluorescence emissions of (A) the K253Q and (B) the Y416T CgIDH mutants in the 
presence of 0 mM (dark blue), 0.4 mM (pink), 0.8mM (orange) and 1.6 mM (sky blue) isocitrate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 Discussion 
4.1 Conformational changes of monomeric IDH upon the substrate(s) binding 
   4.1.1 Domain movement observed between the structures of CgIDH complexed with Mg2+ and 
AvIDH complexed with isocitrate-Mn2+  
     The overall secondary and tertiary structures were similar between the structures of CgIDH 
complexed with Mg2+ and of AvIDH complexed with isocitrate-Mn2+. When the structure of 
CgIDH complexed with Mg2+ was superimposed on the structure of AvIDH complexed with 
isocitrate-Mn2+, using the LSQKAB (Kabsch, 1976) from the CCP4 package (CCP4, 1994), the 
structure of CgIDH complexed with Mg2+ showed a more open conformation than did the 
structure of AvIDH complexed with isocitrate-Mn2+ (Figure 4.1). A large domain (Domain II) 
appeared to shift more toward the cleft relative to the small domain (Domain I) when isocitrate-
Mn2+ was bound to AvIDH. The root-mean-square (r.m.s.) difference between the equivalent α-
carbon atoms of Domain I and Domain II of the two structures is ~0.8 Å and ~1.8 Å, 
respectively. Domain I of CgIDH and AvIDH were overlaid by use of LSQKAB, and the 
rotation angle of Domain II of CgIDH with respect to Domain II of AvIDH complexed with 
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isocitrate-Mn2+ was calculated to be ~ 24˚, which makes Domain II of AvIDH closer to Domain I 
than Domain II of CgIDH (Figure 4.2). 
(A) (B)  
Figure 4.1 Surface representations of the structures of (A) AvIDH complexed with isocitrate-
Mn2+ and of (B) CgIDH complexed with Mg2+. 
   Surface representations of the structures of (A) AvIDH complexed with isocitrate-Mn2+ and of 
(B) CgIDH complexed with Mg2+ were adapted and obtained from Yasutake et al., 2003, and 
from the program GRASP (Nicholls et al., 1991), respectively. Domain I and Domain II are 
indicated as I and II in (B), respectively. 
 
 
              
Figure 4.2 Stereo diagram of the superimposed structures of CgIDH complexed with Mg2+ and 
of AvIDH complexed with isocitrate-Mn2+. 
   Domain I (I) of the structure of CgIDH complexed with Mg2+ (red colored ribbon at the left 
side of the structure) was superimposed onto Domain I of the structure of AvIDH complexed 
with isocitrate-Mn2+ (green colored ribbon) using the LSQKAB from the CCP4 (Kabsch, 1976; 
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CCP4, 1994). Isocitrate and Mn2+ are drawn as yellow stick bonds. The figure was produced 
using Setor (Evans, 1993).  
 
     The superimposed structure of CgIDH complexed with Mg2+ onto the structure of AvIDH 
complexed with isocitrate-Mn2+ revealed that the analogous residues at the isocitrate-Mn2+ 
binding site of CgIDH had moved in concert with the domain shift (Figure 4.3). Most residues at 
the active site are donated from Domain II, especially Arg143, Lys253, Asp346, and Tyr416, 
were shifted more than 5 Å, compared to the equivalent residues present in AvIDH. Because the 
domain shift opens up the active site located at the cleft region between the two domains in the 
structure of CgIDH complexed with Mg2+, these residues were correspondingly further apart. 
When isocitrate was modeled at the equivalent position in the structure of CgIDH complexed 
with Mg2+, by superimposing the two enzyme structures, isocitrate would be further away from 
the analogous active site residues of Domain II in CgIDH. Thus, the analogous active site 
residues in CgIDH can no longer interact with isocitrate due to the open conformation (Figure 
4.4). It is clearly indicated that the open cleft in the structure of CgIDH could no longer mediate 
interaction of isocitrate with the residues at the active site. These observations lead to the 
proposal that this open conformation could be a form of CgIDH that allows substrate to enter and 
then two domains move together to bind substrate at the active site for catalysis to occur.  
               
Figure 4.3 Stereo diagram of the movements of the residues at the isocitrate-Mn2+ binding site in 
the structure of CgIDH complexed with Mg2+. 
     A portion of the backbone of each protein structure of CgIDH complexed with Mg2+ and of 
AvIDH complexed with isocitrate-Mn2+ is drawn as gray ribbon, while the labeled residues at the 
active site are drawn as blue (AvIDH) and as red (CgIDH) sticks. The isocitrate and Mn2+ 
(yellow) are bound at the active site, and the bound Mg2+ in CgIDH is drawn as a pink sphere. 
This picture was produced using Setor.  
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Figure 4.4 Stereo diagram of the structural model of CgIDH complexed with Mg2+ and 
isocitrate-Mn2+. 
    Isocitrate-Mn2+ (yellow) was modeled in the structure of CgIDH complexed with Mg2+ (pink 
sphere) at the equivalent positions of the active site. The active site residues coordinating 
isocitrate-Mn2+ are drawn as colored stick bonds while the light green ribbon represents the 
backbone of the protein. The dashed lines connect isocitrate and Mg2+.  
 
     Due to highly conserved structural features between CgIDH and AvIDH, it is expected that 
CgIDH could undergo a conformational change when isocitrate is bound to the enzyme. 
Fluorescence spectroscopic studies showed the changes in the fluorescence emission of CgIDH 
in the presence of isocitrate, indicating that the conformational changes could be induced upon 
binding of isocitrate to CgIDH in solution. Taken together with the structural observation, it is 
suggested that the domain shift in CgIDH could be induced upon binding of isocitrate at the 
active site.  
 
4.1.2 Coordination geometry of Mg2+ and Mn2+ 
NADP+-dependent IDH is one of the metalloproteins, and it requires either Mg2+ or Mn2+ 
for catalysis. One Mg2+ was found in the structure of CgIDH in the absence of isocitrate and 
NADP+. In the structure of CgIDH complexed with Mg2+, Mg2+ was hexa-coordinated by side 
chains of Asp346Oδ1, Asp544Oδ2, and Asp548Oδ1, the carbonyl oxygen of the main chain of 
Asp544, and two water molecules, whereas Mn2+ in the structure of AvIDH complexed with 
isocitrate-Mn2+ was hexa-coordinated by two Asp residues, two water molecules and two oxygen 
atoms of isocitrate (Figure 4.5 A and B). Because of the absence of isocitrate in the structure of 
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CgIDH, Mg2+ seemed to be coordinated by an extra Asp residue, Asp548, and by the carbonyl 
oxygen of the main chain of Asp544. Due to the open conformation, the Mg2+ was also 
positioned further way from the corresponding residues that interact with isocitrate in the 
structure of complex of AvIDH. From the superimposed structure of CgIDH complexed with 
Mg2+ onto the structure of AvIDH complexed with isocitrate-Mn2+, the corresponding distance 
from Mg2+ to one of the oxygen atoms of isocitrate (which coordinates Mn2+ in AvIDH) 
increased from 2.1 Å to ~8.2 Å (Figure 4.6). It is, therefore, proposed that position of Mg2+ 
moves in concert with the conformational change in the presence of isocitrate and then 
coordinates isocitrate at the active site for catalysis.  
     Furthermore, previous kinetic studies showed that CgIDH has 10-fold lower Km value toward 
isocitrate than homodimeric EcIDH (Chen and Yang, 2000). This specificity of CgIDH toward 
isocitrate implies that the presence of isocitrate is required to coordinate the divalent metal cation 
(either Mg2+ or Mn2+), which consequently induces a closed conformation and allows the 
interaction between isocitrate and the divalent metal cation at the active site for catalysis. 
 
 
 
 
(A) 
 
(B) 
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Figure 4.5 Stereo diagrams of the coordination geometries for the divalent metal cations in the 
structures of (A) CgIDH complexed with Mg2+ and of (B) AvIDH complexed with isocitrate-
Mn2+.  
     The coordinating residues are drawn in green, while isocitrate-Mn2+ and Mg2+ are drawn in 
yellow and pink, respectively. The blue spheres represent water molecules. 
 
 
 
            
Figure 4.6 Stereo diagram of the superimposed active sites of the structures of CgIDH 
complexed with Mg2+ and AvIDH complexed with isocitrate-Mn2+. 
     While Mg2+ (pink sphere) is coordinated by three Asp residues in CgIDH (red), Mn2+ (yellow 
sphere) is coordinated by two Asp residues (green) and isocitrate (yellow) in AvIDH. Two water 
molecules coordinating Mg2+ or Mn2+ are not drawn. The residue names and numbers are written 
in black for AvIDH and in red for CgIDH. This figure was produced using Setor. 
 
4.1.3 Domain movement induced upon binding of NADP+ in monomeric IDH 
A domain shift between the structures of AvIDH complexed with isocitrate-Mn2+ and 
complexed with NADP+ has been proposed (Yasutake et al., 2003). When the structure of 
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CgIDH complexed with Mg2+ was superimposed onto the structure of AvIDH complexed with 
NADP+, Domain II was even more shifted towards Domain I than the one observed in the 
structure of AvIDH complexed with isocitrate-Mn2+ (Figure 4.7). Domain II of the structure of 
CgIDH complexed with Mg2+ appeared to rotate by ~35˚ relative to Domain II of the structure of 
AvIDH complexed with NADP+. Unlike the residues of Domain I at the isocitrate-Mn2+ binding 
site, the equivalent superimposed residues at the NADP+-binding site of the structure of CgIDH 
complexed with Mg2+ onto those in the structure of AvIDH complexed with NADP+ were 
correspondingly close in positions (Figure 4.8). The stabilizing loop for the NADP+ binding 
(described in the structure of AvIDH complexed with NADP+) (Yasutake et al., 2003), however, 
appeared to shift away from the ribose moiety of NADP+ in CgIDH (Figure 4.8). The side 
chains of Arg600 and Arg649 also seemed to rotate toward the 2’-phosphate moiety in the 
presence of NADP+, which allows these residues to interact with NADP+. Since these Arg 
residues at the NADP+-binding site were less affected by a domain shift induced in the presence 
of isocitrate-Mn2+, binding of NADP+ may result in not only a more closed conformation at the 
active site but also in the movements of the residues interacting with NADP+ during catalysis.  
 
(A)  (B)     
Figure 4.7 Surface representations of the structures of (A) CgIDH complexed with Mg2+ and of 
(B) AvIDH complexed with NADP+. 
     The surface representations of the structures of (A) CgIDH complexed with Mg2+ and of (B) 
AvIDH complexed with NADP+ are produced GRASP program (Nicholls et al., 1991) and are 
adapted from the Yasutake et al., 2003, respectively. Domain I and Domain II are indicated as I 
and II, respectively. 
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Figure 4.8 Stereo diagram of the NADP+ binding site in the superimposed structure of CgIDH 
complexed with Mg2+ onto the structure of AvIDH complexed with NADP+. 
     NADP+ (yellow) is bound in the structure of AvIDH (green), which was superimposed onto 
the structure of CgIDH (pink). The residues to coordinate NADP+ were drawn as green (for 
AvIDH) and red (for CgIDH) stick bonds. The stabilizing loop in the structure of AvIDH 
complexed with NADP+ is indicated by a black arrow. The residue names and numbers are 
written in black for AvIDH and in red for CgIDH.  
 
     From fluorescence spectroscopic studies, a significant reduction of the fluorescence emission 
was observed in CgIDH in the presence of NADP+ than occurs in the presence of isocitrate. The 
increase in the fluorescence emission indicates that binding of NADP+ could produce a larger 
conformational change in CgIDH than does binding of isocitrate. Both structural overlay and 
fluorescence spectroscopic studies agreed that binding of NADP+ to monomeric IDH could 
induce greater conformational changes than occurred for the binding of isocitrate-Mn2+.  
A question raised here is whether this further closed conformation induced upon binding 
of NADP+ is an active or inactive form. The Asp350 and Asp548 (that coordinate the divalent 
metal cation) were oriented close to each other in the closed conformation of the structure of 
AvIDH complexed with NADP+, which could not provide enough space for binding of isocitrate-
Ca2+, and therefore the closed conformation could be an inactive form (Yasutake et al., 2003). 
Previous studies have also suggested that CgIDH has 3-fold lower Km for NADP+ (Km = 4 µM) 
than did homodimeric EcIDH (Km = 11 µM) (Chen and Yang, 2000). Thus, the high affinity of 
NADP+ for monomeric IDH seems to cause the further closed conformation, to which isocitrate-
Ca2+ can no longer bind. Isocitrate-Ca2+ has lower affinity than NADP+ and isocitrate-Mn2+ for 
AvIDH (Barrera and Jurtshuk, 1970).  
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Fluorescence spectroscopic studies of CgIDH, on the other hand, showed the quenching 
of the fluorescence emission when NADP+ was added regardless of the presence of isocitrate in 
solution (Figure 3.14). It is indicated that binding of NADP+ by itself may induce a further 
conformational change in CgIDH even in the presence of isocitrate. It is not clear if the 
additional quenching of the fluorescence emission is directly related to a more closed 
conformation. The quenching of the fluorescence emission of CgIDH by adding isocitrate in the 
presence of NADP+ or by adding NADP+ in the presence of isocitrate, suggests that the 
conformational change could occur in a reversible manner, probably due to the energetic 
similarity between the open and the closed conformations in CgIDH. It is presumed that the 
closed conformation induced upon binding of NADP+ could be easily reversed to the partially 
open conformation, to which isocitrate-Mn2+ could bind for catalysis. From both structural 
observations and fluorescence spectroscopic studies, it is also proposed that the reversible 
conformational changes could mediate the specificity of monomeric IDH (CgIDH and AvIDH) 
toward NADP+ and could discriminate between the inhibitor (isocitrate-Ca2+ in this case) and the 
substrate (isocitrate-Mn2+) binding to this enzyme.  
 
 
4.2 Evolutionary relationship among the IDH family 
4.2.1 Two inter-convertible conformations present in the IDH enzyme family  
     Exhibiting a conformational change is one of the common characteristics of some enzymes 
during catalysis. Unlike NAD+-dependent IDH, NADP+-dependent IDH enzymes are not 
allosterically regulated (Chen and Gadal, 1990). Homodimeric EcIDH is well known to be 
regulated through the phosphorylation cycle catalyzed by IDHK/P (LaPorte, 1993). When 
EcIDH is phosphorylated at Ser113, it is inactivated, but a conformational change was not 
observed between the structures of dephosphorylated and phosphorylated EcIDHs (Hurley et al., 
1990). It has been suggested, however, that the open conformation could be required in EcIDH 
for the accessibility of IDHK/P to phosphorylate EcIDH (Finer-Moore et al., 1997). From the 
solved structures, the domain shift by a rotation angle of ~19° was observed only between the 
substrate-free open conformation and substrate (either isocitrate-Mg2+ or NADP+) bound closed 
conformation in EcIDH (Figure 4.9) (Finer-Moore et al., 1997). The superimposed structures of 
the Ser113Glu EcIDH mutant and of the wild type EcIDH complexed with isocitrate-Mg2+ 
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showed an interdomain rotation by ~ 4º (Hurley et al., 1990; Doyle et al., 2001), while the 
rotation angle between the structures of EcIDH complexed with isocitrate-Mg2+ and complexed 
with α-ketoglutarate-Ca2+ and NADP+ is less than 1º (Hurley et al., 1990; Stoddard and 
Koshland, 1993). Although no significant domain shift was observed between the structures of 
EcIDH complexed isocitrate-Mg2+ and complexed with NADP+ (Hurley et al., 1991), local 
conformational changes at the active sites have been reported from the structures of complexes 
EcIDH and its mutants (LaPorte, 1993; Stoddard and Koshland, 1993). From these studies, it has 
been proposed that conformational changes may exist in EcIDH to allow the binding of its 
substrate(s) and to allow phosphorylation of EcIDH by IDHK/P (Finer-Moore et al., 1997; 
Mesecar et al., 1998).  
 
             
Figure 4.9 Stereo diagram of the superimposed structures of the open and closed conformation of 
EcIDH. 
     The open conformation of EcIDH in the absence of substrates (red ribbon) was superimposed 
onto the structure of EcIDH complexed with isocitrate-Mg2+ (green ribbon). Only one subunit of 
the homodimeric EcIDH is presented. The isocitrate and Mg2+ are drawn as yellow stick bonds 
and a sphere, respectively, at the active site. The figure was produced using Setor.  
 
     The structures of IMDH that are closely related to EcIDH, have also demonstrated that two 
conformations could exist, and that a similar domain shift appeared to close the active site 
(Wallon et al., 1997). The domain is rotated by ~16° relative to another domain, which exhibits 
less rotation of the domain than the rotation angle observed in the structures of wild-type EcIDH, 
but more than the one between the structures of Ser113Glu EcIDH mutant and of wild-type 
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EcIDH. The relatively small interdomain rotation angle observed in the structures of IMDH may 
be due to the fact that the isopropylmalate was absent in the structure of IMDH complexed with 
Mn2+ and SO42- (Figure 4.10). 
 
               
Figure 4.10 Stereo diagram of the superimposed structures of the IMDH in the presence and the 
absence of Mn2+ and SO42-. 
     The structure of EcIMDH in the absence of substrate (green ribbon) was superimposed onto 
the structure of StIMDH complexed (red ribbon) with Mn2+ and SO42- (purple sphere and stick 
bonds, respectively). The figure was produced using Setor. 
 
     In addition to prokaryotic homodimeric IDH and the IMDH enzyme family, the mammalian 
homodimeric IDH seemed to undergo conformational changes. The structure of HcIDH 
complexed with NADP+ exhibited a more open conformation than did the structure of HcIDH 
complexed with isocitrate-Ca2+ and NADP+ (Xu et al., 2004). The domain shift from the 
structure of HcIDH complexed with isocitrate-Ca2+ and NADP+ to the other structure of HcIDH 
complexed with NADP+, appeared to close the active site by a rotation angle of ~ 27° (Figure 
4.11). When the structure of HcIDH complexed with isocitrate-Ca2+ and NADP+ was 
superimposed onto the structure of PmIDH complexed with isocitrate-Mn2+, both structures 
essentially coincided, indicating that the closed conformation could be the active form in the 
mammalian homodimeric IDH (Figure 4.12). Because the phosphorylation of the HcIDH has not 
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been reported up date, it has been proposed that the conformational change of HcIDH could be 
induced upon binding of isocitrate and could be directly related to the regulation of enzymatic 
activity in HcIDH (Xu et al., 2004). 
 
            
Figure 4.11 Stereo diagram of the superimposed structures of HcIDH complexed with isocitrate-
Ca2+ and NADP+ and with only NADP+. 
     The structure of HcIDH complexed with isocitrate-Ca2+ and NADP+ (green ribbon) was 
superimposed onto the structure of HcIDH complexed with only NADP+ (red ribbon), whereas 
NADP+ (yellow stick bonds) is bound at the active site. The figure was produced using Setor. 
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Figure 4.12 Stereo diagram of the superimposed structures of PmIDH complexed with isocitrate-
Mn2+ and of HcIDH complexed with isocitrate-Ca2+ and NADP+. 
     The structure of HcIDH complexed with isocitrate-Ca2+ and NADP+ (green ribbon) was 
superimposed onto the structure of PmIDH complexed with isocitrate-Mn2+ (red ribbon). Only 
isocitrate-Mn2+ in the structure of PmIDH complexed with isocitrate-Mn2+ is drawn in yellow. 
The figure was produced using Setor.  
 
     The domain movement observed from the structure of CgIDH complexed with Mg2+ to the 
structure of complexes of AvIDH (isocitrate-Mn2+ and NADP+ complexes) appeared to close the 
cleft region that is homologous to the active site observed in the structures of EcIDH (Figure 
4.9), IMDH (Figure 4.10), and HcIDH (Figure 4.11), indicating the similar conformational 
changes that occur in monomeric and homodimeric IDH enzymes (Figure 4.13). It is also 
suggested that the closed conformation in monomeric IDH could be the active catalytic form and 
could be induced upon its substrate(s) binding. These similar conformational changes upon the 
substrate(s) binding support the hypothesis that both homodimeric and monomeric IDH could 
have evolved from the same ancestral protein (Chen and Yang, 2000; Yasutake et al., 2002, 
2003). The rotation angle observed from the domain shifts in monomeric IDH are larger than the 
rotation angles calculated in the structures of complexes of EcIDH and IMDH, but are similar to 
the rotation angles between the complex structures of complexes of HcIDH (Table 4.1). The 
larger rotation angles may be due to more flexibility of monomeric IDH and homodimeric 
HcIDH than of homodimeric EcIDH and IMDH. The similar rotation angles observed from the 
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domain shift in the structures of monomeric IDH and homodimeric HcIDH also suggest that 
monomeric IDH may be more closely related to mammalian homodimeric HcIDH rather than to 
prokaryotic homodimeric EcIDH and IMDH. Based on the similar topological features among 
homodimeric IMDH, homodimeric IDH, and monomeric IDH enzymes, it is proposed that the 
open and the closed forms of monomeric CgIDH could be energetically inter-convertible during 
substrate binding and catalysis. 
 
 
 
 
 
 
 
 
 
(A) 
 
(B) 
 110
111 
 
Figure 4.13 Stereo diagrams of the overlaid structures of CgIDH complexed with Mg2+ and the 
structures of AvIDH complexed (A) with isocitrate-Mn2+ or (B) with NADP+. 
   (A) The structure of CgIDH complexed with Mg2+ was superimposed onto the structures of 
AvIDH complexed with isocitrate-Mn2+ (green ribbon). Isocitrate and Mn2+ are drawn as yellow 
stick bonds at the active site. (B) The structure of CgIDH complexed with Mg2+ was 
superimposed onto the structures of AvIDH complexed with NADP+ (green ribbon). NADP+ is 
drawn as pink stick bonds at the active site. These diagrams were produced using Setor. 
 
 
 
 
A pair of the 
domain in the 
protein structures 
compared 
Rotation 
angle (°) 
calculated 
1AI2 5ICD 0.65 
1HJ6 5ICD 4.1 
1SJS 5ICD 19.3 
1CNZ 1CM7 15.7 
1TO9 1TOL 27.2 
1J1W 1ITW 12.6 
CgIDH 1ITW 23.9 
CgIDH 1J1W 35.2 
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Table 4.1 Rotation angles observed in the structures of homodimeric IDH, homodimeric IMDH 
and monomeric IDH enzymes. 
     The rotation angle of the domain between two structures was calculated using the LSQKAB 
from the CCP4 package (Kabsch, 1976; CCP4, 1994). The accession codes for PDB files are 
1AI2 (the structure of EcIDH complexed with isocitrate-Ca2+ and NADP+), 5ICD (the structure 
of EcIDH complexed with isocitrate-Mg2+), 1HJ6 (the structure of the Ser113Glu EcIDH mutant 
complexed with isopropylmalate-Mg2+), 1CNZ (the structure of StIMDH complexed with Mn2+ 
and SO42-), 1CM7 (the structure of EcIMDH in the absence of substrate), 1TO9 (the structure of 
HcIDH complexed with isocitrate-Ca2+ and NADP+), 1TOL (the structure of HcIDH complexed 
with NADP+), 1ITW (the structure of AvIDH complexed with isocitaret-Mn2+) and 1J1W (the 
structure of AvIDH complexed with NADP+). The structure of CgIDH complexed with Mg2+ is 
indicated as CgIDH. 
 
     4.2.2 Conserved isocitrate and a divalent metal cation binding sites among the IDH enzyme 
family 
     Regardless of the amino acid sequence alignments that show less than 10% identity between 
homodimeric EcIDH and monomeric IDH, isocitrate and a divalent metal cation binding site 
were well conserved among the structures of EcIDH and monomeric IDH complexes as well as 
in PmIDH and HcIDH complexes. The equivalent residue to Ser113 in EcIDH was identified 
from the structures of complexes of CgIDH and AvIDH, which is completely conserved among 
monomeric IDH enzymes from other sources (Figure 3.10). The equivalent residue to Lys230´ in 
EcIDH, Lys253 in CgIDH, was also completely conserved in both homodimeric and monomeric 
IDH (Figure 3.10).  
The coordination geometries of isocitrate and Mn2+ in the structure of the complex of 
AvIDH were similar to those in the structures of complexes of EcIDH, PmIDH, and HcIDH. 
Isocitrate is coordinated by equivalent Ser, Arg, Lys, and Tyr residues, and the divalent metal 
cation is coordinated by the equivalent Asp residues, two water molecules, and two oxygen 
atoms of isocitrate (Figure 4.14). One major difference is the absence of the second active site in 
monomeric IDH due to the lack of the domain that is equivalent to Domain A´ in the second 
subunit of homodimeric IDH (Figure 1.16). Beside the absence of the second active site, the 
structures of both homodimeric and monomeric IDH established that the well-conserved active 
site could be formed for the identical catalysis even though their primary structures were < 10% 
identical. These conserved active sites imply not only the evolutionary relationship among 
homodimeric and monomeric IDH enzymes but also similar tertiary structures for the proteins 
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that catalyze the identical reaction but have minimal identity of amino acid sequence to other 
members of the enzyme family. 
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Figure 4.14 Stereo diagrams of the conserved isocitrate and a divalent metal cation binding sites 
among the structures of homodimeric and monomeric IDH. 
     Isocitrate and a divalent metal cation binding site in each structure of (A) EcIDH complexed 
with isocitrate-Mg2+, of (B) PmIDH complexed with isocitrate-Mn2+, of (C) HcIDH complexed 
with isocitrate-Ca2+, and of (D) AvIDH complexed with isocitrate-Mn2+. The residues at the 
active site are drawn in green, while the isocitrate and a divalent metal cation are drawn in 
yellow. The blue spheres represent water molecules.  
 
     4.2.3 The unique stabilizing loop at the NADP+-binding sites in monomeric IDH 
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The structure of AvIDH complexed with NADP+ revealed that the residues at the NADP+ 
binding site observed from the structure of complex of AvIDH were well conserved among 
monomeric IDH from other sources including CgIDH, but were different from the residues in 
homodimeric EcIDH (Yasutake et al., 2003). It has been suggested that the NADP+ binding site 
in monomeric AvIDH could be more similar to the one in HcIDH rather than to the one in 
EcIDH (Yasutake et al., 2003). The residues identified to coordinate the moieties of NADP+ in 
the structures of AvIDH, HcIDH, and EcIDH complexed with NADP+ are summarized in Table 
4.2. While Tyr345 and Tyr391 have been suggested as critical residues to coordinate the 2’-
phosphate moiety of NADP+, His and Arg residues coordinated the NADP+ at the equivalent 
positions in the structures of complexes of both AvIDH and HcIDH (His589 and Arg649 in 
AvIDH, and His315 and Arg314 in HcIDH) (Figure 3.10). Three continuous non-charged amino 
acid residues, Gly-Ser (Thr in HcIDH)-Ala (Val in HcIDH), also stabilized the ribose and 
diphosphate moieties in both of these structures. Two Ser residues also coordinated the 
nicotinamide moiety of NADP+ in the structure of AvIDH complexed with NADP+, as did two 
Thr residues in HcIDH (Yasutake et al., 2003; Xu et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moiety of NADP+ EcIDH HcIDH AvIDH 
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Adenine Tyr345 His309 Trp601 
  Gly321 Val312  
 Asn392 Thr327  
 Asp352 Asn328 Asp602 
2’-phosphate Tyr391 Arg314 Arg649 
 Tyr345 His315 His589 
 Arg395  Arg600 
Ribose  Leu288  
and diphosphate  Gly310 Gly584 
  Thr311 Ser585 
 Ala342 Val312 Ala586 
Nicotinamide Thr104 Thr311 Ser585 
  Thr75 Ser87 
  Lys72  
  Arg82  
  Asn96 Asn85 
Table 4.2 The equivalent interacting residues for NADP+ in EcIDH, HcIDH, and AvIDH. 
The equivalent residues to coordinate NADP+ were identified from the structures of 
EcIDH (Hurley et al., 1991), HcIDH (Xu et al., 2004), and AvIDH (Yasutake et al., 2003) 
complexed with NADP+. The red highlighted residues were those in each of the complex 
structures that coordinate 2’-phosphate of NADP+ specific recognition. The semi-conserved 
residues between HcIDH and AvIDH to coordinate the ribose and diphosphate are highlighted in 
blue. 
 
 
     The structure of HcIDH complexed with NADP+ also revealed that the hydrogen bonding 
between Ser95 and Asp279 was formed in the absence of isocitrate-Ca2+, and that Arg314 could 
extend its side chain toward NADP+ when isocitrate-Ca2+ was bound (Xu et al., 2004). The 
similar reorientation of the equivalent Arg residue(s) at the NADP+ binding site was observed 
when the closed conformation of AvIDH complexed with NADP+ was superimposed onto the 
open conformation of CgIDH complexed with Mg2+ (Figure 4.15). The side chains of two Arg 
residues (Arg600 and Arg649 in AvIDH) seemed to rotate toward NADP+ when it is bound. 
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Thus, it is consistent that binding of NADP+ could induce the reorientation of the equivalent Arg 
residues(s) in HcIDH and in monomeric IDH (AvIDH and CgIDH).  
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Figure 4.15 Stereo diagrams of the reorientation of Arg residue at the NADP+ binding site in 
structures of HcIDH and AvIDH complexed with NADP+. 
     (A) The structure of HcIDH complexed with NADP+ (green) was superimposed onto the 
structure of HcIDH complexed with isocitrate-Ca2+ and NADP+ (blue). The Arg residue that is 
rotated is indicated by dashed line, while NADP+ is drawn in yellow color. (B) The structure of 
CgIDH complexed with Mg2+ (blue) was superimposed onto the structure of AvIDH complexed 
with NADP+ (green). The two Arg residues are indicated as arrows, while NADP+ and Mg2+ are 
drawn in yellow and pink colors.   
 
     In terms of the overall structures, however, the structure of AvIDH complexed with NADP+ 
exhibited a closed conformation, while an inactive open conformation was observed from the 
structure of HcIDH complexed with NADP+. There are two possible explanations to observe two 
different conformations in the structures complexed with NADP+. It is noteworthy that the 
crystallization for this AvIDH complex has been carried out in the presence of both NADP+ and 
isocitrate-Ca2+, not in the presence of NADP+ only as was done for the crystallization of the 
HcIDH complex. The presence of both NADP+ and isocitrate-Ca2+ for crystallization of this 
AvIDH complex probably could exclude isocitrate-Ca2+ from binding to the closed conformation 
of AvIDH complexed with NADP+, resulting in an inhibition of AvIDH. Thus, the crystallization 
conditions could affect the conformation of the protein in the crystal. Another possibility for the 
closed conformation of AvIDH complexed with NADP+ is that AvIDH may have a unique 
mechanism to regulate the binding of NADP+, which makes this enzyme more specific toward 
NADP+. Previous studies showed that CgIDH had a highly specific affinity for NADP+ (Chen 
and Yang, 2000). Due to the completely conserved residues at the NADP+ binding site and 
similar topological features between AvIDH and CgIDH, NADP+ could be coordinated in an 
identical manner in these monomeric IDH enzymes and could possess the similar high specificity 
toward NADP+. The superimposed structures of CgIDH complexed with Mg2+ onto AvIDH 
complexed with NADP+ revealed that the stabilizing loop for NADP+ could be shifted along with 
the domain movement (Figure 4.8), whereas this stabilizing loop was absent in EcIDH and 
HcIDH (Yasutake et al., 2003; Xu et al., 2004). Thus, the presence of this unique stabilizing loop 
for NADP+ indicates that NADP+ could bind to the active site better in monomeric IDH than in 
homodimeric EcIDH and HcIDH.  
Fluorescence spectroscopic studies of CgIDH also agreed that the conformational change 
occurred in the presence of either NADP+ or isocitrate. Taken together with the observation of 
the two inter-convertible conformations in homodimeric and monomeric IDH, it is proposed that 
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monomeric IDH could have a closed conformation when either NADP+ or isocitrate is bound due 
to the specificity of this enzyme toward NADP+ and isocitrate. Therefore, the NADP+ binding 
site in monomeric IDH was similar to the one in mammalian homodimeric HcIDH but in 
addition may have a unique stabilizing loop that could allow NADP+ to bind better and to induce 
conformational changes for stabilization of NADP+ at the active site in monomeric IDH. 
Similarly, binding of isocitrate and a divalent metal cation (Mg2+ or Mn2+) could cause 
conformational changes in monomeric and homodimeric IDH enzymes.  
 
 
4.3 Kinetic properties of monomeric IDH  
4.3.1 Regulation of enzymatic activity in monomeric IDH 
     The structure of CgIDH complexed with Mg2+ revealed the open conformation, compared to 
the structures of AvIDH complexed with isocitrate-Mn2+ and with NADP+. If the open 
conformation is a form that allows the substrate(s) to enter, and if the coordinating residues of 
the substrate(s) are shifted along with the domain movement, the domain shift observed in these 
structures of complexes of CgIDH and AvIDH may be involved in the regulation of the 
enzymatic activity in monomeric IDH. In the presence of isocitrate or NADP+, monomeric IDH 
could assume the closed conformation, where this enzyme can interact with the substrate at the 
active site. Similar to homodimeric HcIDH, the open and closed conformations of monomeric 
IDH could be energetically inter-convertible, and monomeric IDH might display different 
conformations depending on the presence of certain substrates or inhibitors. The specificity of 
isocitrate and NADP+ proposed in CgIDH could be due to the sensitivity of the domain shift on 
the substrate(s). Thus, CgIDH could form the active conformation possibly in the presence of 
isocitrate-Mn2+/ isocitrate- Mg2+ or NADP+, but not in the presence of Mn2+/ Mg2+ only or 
inhibitor(s) that have lower affinity to the enzyme. The binding of NADP+ could result in 
regulation of the enzyme activity.  
     The phosphorylation cycle to control the enzymatic activity has been reported only in 
homodimeric EcIDH among homodimeric and monomeric IDH enzymes (LaPorte, 1993). The 
site-directed mutagenesis studies on CgIDH showed that the equivalent residue to Ser113 in 
EcIDH, Ser130 in CgIDH, could not completely inactivate CgIDH even when it was replaced by 
a negatively charged Asp. Rather, the K253Q and Y416T CgIDH mutants appeared to inactivate 
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CgIDH, indicating that these residues may play critical roles in the enzymatic activity of CgIDH. 
The presence of the detectable 7% enzymatic activity in the S130D CgIDH mutant but not in the 
K253Q and the Y416T CgIDH mutants suggest that the activity in CgIDH may not be regulated 
by phosphorylation. Since both the equivalent Lys and Tyr residues have been suggested to be 
critical for the enzymatic activity of PmIDH, the kinetic studies of these CgIDH mutants also 
support the hypothesis that CgIDH (monomeric IDH) may be more similar to the homodimeric 
HcIDH and PmIDH than to homodimeric EcIDH, in terms of the regulation of their enzymatic 
activities.  
     The enhanced fluorescence emission observed in the K253Q and Y416T CgIDH mutants in 
the presence of isocitrate suggest that these mutants may cause some different conformational 
changes when isocitrate is bound. The types of the conformational changes for these mutants 
could not be determined from the fluorescence spectroscopy studies. Because these Lys253 and 
Tyr416 residues were observed to be shifted further away from the closed to the open 
conformations in monomeric IDH, and because the substitution of Lys or Tyr by Asp or Thr, 
respectively, shortens the side chain at each position, it is expected that these mutant proteins 
may be unable to form the active conformation of CgIDH, resulting in the inactivation of these 
mutants. The absence of any changes in the fluorescence emission for the S130D CgIDH mutant, 
on the other hand, indicates that this mutant may bind to isocitrate but may not undergo any 
conformational changes. Since Ser130 was identified to interact with isocitrate like Ser113 in 
EcIDH, the mutation of this Ser residue could interfere with proper binding of isocitrate to the 
enzyme, which results in not only a decrease in the enzymatic activity but also the absence of the 
conformational change that occurs when isocitrate is bound. From these structural analyses 
together with fluorescence spectroscopic and site-directed mutagenesis studies of CgIDH, it is 
proposed that the conformational changes in the presence of substrate(s) may have essential roles 
in the regulation of enzymatic activity of monomeric IDH since these active site residues would 
be reoriented to interact with the substrate by the domain movement.  
 
   4.3.2 The proposed reaction mechanism in monomeric IDH 
     Based on the structures of complexes of homodimeric EcIDH, two steps in the oxidation of 
isocitrate have been suggested in EcIDH (Figure 1.1) (Hurley et al., 1991; Dean and Koshland, 
1993). The similar catalytic mechanism has been postulated for homodimeric PmIDH (Kim et 
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al., 2003). Due to the well conserved active site between homodimeric and monomeric IDH, it is 
conceivable that monomeric IDH catalyzes the decarboxylation of isocitrate in two steps (Figure 
4.16). First, a proton is removed from isocitrate by a general base, and a hydride ion is 
transferred to NADP+, resulting in the formation of oxalosuccinate. Then, the β-carboxylate of 
oxalosuccinate is lost by releasing CO2, followed by the protonation of the β-carbon of α-
ketoglutarate. Either Mg2+ or Mn2+ stabilizes the α-carboxylate and the C2 enolate ion of 
isocitrate throughout catalysis.  
 
           
 
Figure 4.16 The proposed reaction mechanism for monomeric IDH. 
     Two steps in the decarboxylation of isocitrate are proposed as the catalytic reaction 
mechanism in CgIDH. The half-arrows represent the directions of the catalytic reaction and the 
release of products (NADPH and CO2), and the full-arrows indicate the movements of electrons 
in the reaction. The coordination of the divalent metal cation (M2+), Mg2+ or Mn2+, is drawn as a 
dashed line. A general base (B) and a general acid (A) are active site residues from CgIDH. 
 
     The mechanism of the interaction between monomeric IDH and the substrate(s) is similar to 
the one described for homodimeric EcIDH (Dean and Koshland, 1993). Either isocitrate or 
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NADP+ can bind to monomeric IDH and solely induce a closed conformation. Then, another 
remaining substrate can bind to the enzyme in the altered conformation since these closed 
conformations seemed to be energetically similar to each other as well as to the open 
conformation (Figure 4.17). It is not clear if the conformation of monomeric IDH can be further 
altered in the presence of both isocitrate and NADP+ during catalysis. Based on fluorescence 
spectroscopic studies of CgIDH, this enzyme appeared to induce further conformational changes 
in the presence of both isocitrate and NADP+. It is presumed, therefore, that the conformation of 
monomeric IDH may be variable depending on the presence of substrate(s) or inhibitor(s), which 
may play a critical role to control its enzymatic activity. 
 
      
 
Figure 4.17 The proposed mechanism of the interaction between monomeric IDH and its 
substrate(s). 
     Monomeric IDH is labeled as ‘E’ while isocitrate, NADP+, oxalosuccinate, and α-
ketoglutarate are presented as ‘iso’, ‘NADP’, ‘OS’, and ‘KG’, respectively. The half-arrows 
indicate the interaction between monomeric IDH and its substrate(s), whereas a release of carbon 
dioxide is drawn in a full arrow. 
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Chapter 5 Conclusion and future work 
   5.1 Summary of the research project 
     Based on previous preliminary studies, the purification of CgIDH was modified in order to 
minimize the purification steps while purity of the protein was maintained (Figure 3.1) (Bai et 
al., 1999). The optimizations of crystallization and of cryocrystallography were successfully 
done to diffract the CgIDH crystal at higher resolution with lower crystal mosaicity (Table 3.1). 
The CgIDH crystal in the absence of isocitrate and NADP+ diffracted at 1.75 Å resolution. The 
structure was solved using MR and was refined using CNS (Brünger et al., 1998). The structure 
of CgIDH complexed with Mg2+ is composed of two domains, and the active site is formed at the 
cleft region between two domains (Figure 3.5). One magnesium ion was hexa-coordinated by 
three Asp residues and two water molecules in an octahedral geometry at the active site in 
CgIDH. When the structure of CgIDH complexed with Mg2+ was superimposed onto the 
structures of AvIDH complexed with isocitrate-Mn2+ or complexed with NADP+, the domain 
shift was observed, which causes the closure of the active site located between two domains 
(Figures 4.1, 4.2, 4.7, and 4.13). Fluorescence spectroscopic studies suggested that the 
conformational changes occurred in CgIDH by its substrate(s) binding (Figures 3.11). Similar 
domain shifts have been reported in the structures of homodimeric EcIDH, IMDH, and HcIDH 
(Figure 4.9-11). From these observations, it is proposed that the IDH enzyme family could exist 
in the open and the closed conformations that are energetically inter-convertible for catalysis. 
Although the closed conformation was suggested as an active form induced in the presence of 
isocitrate and NADP+, the closed conformation was observed in the structure of AvIDH 
complexed with only NADP+. Fluorescence spectroscopic studies of CgIDH agreed that the 
conformational change could be induced solely by the binding of NADP+ (Figure 3.14). The 
conformational changes observed between the structures of CgIDH complexed with Mg2+ and of 
AvIDH complexed with NADP+, as well as in the quenching of the fluorescence emission in 
CgIDH in the presence of NADP+, presumably explain the specificity and high affinity of 
CgIDH toward NADP+ for catalysis. Yet, it is not clear if isocitrate-Mn2+ may bind to CgIDH 
prior to binding of NADP+ or may bind to CgIDH in the closed conformation induced after 
binding of NADP+.  
     From both site-directed mutagenesis and the fluorescence spectroscopy studies, three newly 
generated CgIDH mutants (S130D, K253Q and Y416T mutants) appeared to have reduced and 
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non-existent specific activities compared to the wild-type enzyme. While the S130D CgIDH 
mutant did not exhibit any conformational changes in the presence of isocitrate, conformational 
changes in the K253Q and Y416T mutants seemed to be induced in the presence of isocitrate 
(Figure 3.15). It is therefore presumed that the mutations of these residues at the active site in 
CgIDH could affect not only the specific activities but also the conformational changes that are 
induced in the presence of isocitrate. It is also proposed that the conformational change in the 
presence of substrate(s) may be involved in the regulation of CgIDH activity; therefore, the 
substitutions of the active site residues could cause the mutant protein not to assemble the active 
conformation properly in the presence of substrate(s). The structural analysis of CgIDH 
compared with homodimeric IDH agreed with the similar topological features between CgIDH 
and homodimeric IDH. The conserved active sites support the hypothesis that both monomeric 
and homodimeric IDH could be evolved from the same ancestral protein. It is also proposed that 
monomeric IDH is more closely related to mammalian homodimeric PmIDH and HcIDH rather 
than to prokaryotic homodimeric EcIDH since the NADP+ binding site in AvIDH and CgIDH 
was more similarly formed to the one in HcIDH (Figure 4.15), and since the binding of isocitrate 
and/or NADP+ could mediate conformational changes in AvIDH, CgIDH, and HcIDH (Figures 
4.9-13). Thus, monomeric IDH, like mammalian homodimeric IDH, may be regulated by the 
self-assembly of the active conformation in the presence of its substrate(s), while the 
phosphorylation cycle controls the enzymatic activity in EcIDH.  
 
   5.2 Future work 
     The structural aspects of CgIDH together with site-directed mutagenesis and fluorescence 
spectroscopic studies revealed that the conformational changes could occur in CgIDH when its 
substrate(s) is(are) bound. From the collected diffraction data sets, the complex CgIDH crystals 
belonged to the same space group, C2, but had different unit cell dimensions, suggesting that the 
substrate was likely bound to the enzyme. Hence, the structures of CgIDH complexed with each 
of NADP+, NAD+, and isocitrate-NAD+ should be solved, in order to display variable 
conformations in the presence of different substrate(s). Yet, it is not known if CgIDH mediates 
different conformations in the presence of inhibitor such as isocitrate-Ca2+ or in the presence of 
its product(s) such as α-ketoglutarate. Furthermore, because the conformational changes were 
indicated for the K253Q and Y416T CgIDH mutants in the presence of isocitrate, the solving of 
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crystal structures of these mutants complexed with isocitrate-Mn2+/Mg2+ or isocitrate-Ca2+ 
should verify whether these mutants would assemble in different conformations or not.  
     The domain shift observed from the open to the closed conformation in the absence and the 
presence of NADP+, respectively, revealed that two Arg residues could be rotated toward 
NADP+ along with the domain shift. Since Arg600 is a unique residue at the NADP+-binding site 
in monomeric AvIDH (Yasutake et al., 2003), the mutation of the equivalent Arg residue in 
CgIDH may elucidate the detailed role of this Arg residue for binding of NADP+ in monomeric 
IDH. Because His589 in the structure of AvIDH complexed with NADP+ was also identified as 
an equivalent to His315 in the structure of HcIDH complexed with NADP+ and interacts with 
NADP+, and because the mutation of this His residue in PmIDH and HcIDH has been reported to 
reduce the binding affinity of homodimeric IDH for NADP+ (Huang et al., 2002), the mutation 
of the equivalent His residue (His584) in CgIDH may confirm the hypothesis that the NADP+-
binding site in CgIDH could be similar to the one in mammalian homodimeric IDH rather than to 
the one in prokaryotic homodimeric EcIDH. 
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